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This thesis evaluates and compares the goodness-of-fit of six stochastic mortality 
models—the Lee-Carter (LC), Renshaw-Haberman (RH), Age-Period-Cohort (APC), 
Cairns-Blake-Dowd models (CBD), M7, and Plat models—with specific reference to 
Australian mortality data. The models are fitted to Australian mortality data for both 
sexes across three age-group stratification (S0, S1 and S2), four look back windows 
(l=20, 30, 40 and 50 years) and five look forward windows (h=1, 5, 10, 15 and 20 
years). For each combination of look back, look forward window and age-groups 
stratification, years spans were adjusted to forecast mortality rates for the years 2007 
to 2011. The six models were evaluated using four different criteria for model 
selection: the root mean square error (RMSE); Bayesian Information Criterion (BIC); 
Akaike Information Criterion (AIC) and heat-maps of residual plots (random/non-
random), each derived using the StMoMo package in R.   
The Results showed that the best look back window is of 20–years and Lee-Carter 
model is a good choice for forecasting Australian mortality rates for both females and 
males when all ages 0-100 are considered. However, the mortality rates are better 
predicted by age wise stratification for ages 60 and higher. The results also indicate 
that in the long-term there is a decreasing trend in Australian mortality rates with more 
than two fold decrease in mortality rates between years 2011 and 2061. 
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Chapter 1 Introduction 
1.1 Background 
The world’s population continues to grow, and with it the importance and application 
of mortality modelling and forecasting. In the course of the 20th century, the 
population experienced a significant change in mortality as mortality rates decreased 
dramatically and life expectancy increased. These continue to change, which 
represents a phenomenon thought to be driven by improving standards of hygiene, 
education, nutrition, living environment and medical care. In Australia, for example, 
life expectancy at birth increased from 70.87 years in 1960 to 82.15 years in 2011.  
Many authors in the theoretical and empirical literature argued that the ability 
to accurately project mortality rates, and their impact on the size and structure of 
populations, is crucial to preparing and providing suitable infrastructure and services 
for the future. Accurate mortality forecasts are essential to planning for the 
development of schools and hospitals, the provision of insurance, pensions and 
welfare, and other important social, economic and health policy decisions (Yeo, Chan 
and Kogure 2012; Hu 2014; Li and O'Hare 2015). Any ability to improve the fit of 
mortality forecasting models could have positive implications in these areas. Thus, it 
is vital that demographers and actuaries can select and apply a mortality model that 
performs effectively for a particular set of economic, geographic and population–based 
parameters. In this case, an effective model is one that fits well with historical data and 
produces apparently plausible forecasts that do not differ significantly from actual 
outcomes ex–post by Dowd, Cairns, Blake, Coughlan, Epstein, and Khalaf–allah 
(2010b).  
Starting with the 19th century when Gompertz (1825) published his law of 
mortality, the availability of different models for mortality forecasting has increased 
dramatically, along with model complexity. Early mortality models are relatively 
simple, comprising linear or quadratic extrapolation of measures such as life 
expectancy and age-specific trends. Such models assume that past trends will continue 
into the future. Although these methods are relatively easy to apply, they often suppose 
a fixed rate of change and can be a poor fit when trends change or if cohort-specific 
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events skew data (World Health Organization 1957; Haines 1977;  Coale, Demeny and 
Vaughan 2013; Brass 2015).  
Over the years, different models have been developed to describe mortality. 
Concepts related to mortality, annuities and adverse risk selection were already 
mentioned in the empirical and theoretical literature of the nineteenth century. In this 
period, the first mortality tables were created in the United Kingdom, which included 
a margin to predict changes in mortality, to protect insurers against losses (Olivieri and  
Pitacco 2009).  
In predicting trends for old age mortality, 85 years has been suggested as a 
biological limit of human life expectancy (Carnes and Olshansky 2007). However, 
others argue there may be no upper limit (Tuljapurkar and  Boe 1998). Thus the quality 
of simple extrapolations may be enhanced by extending models. For example, the 
long-term accuracy of linear extrapolations might be improved by anticipating a 
slowdown in yearly mortality improvements, and mathematically incorporating this 
into the model (Ediev 2008). However, such additions often involve the subjective use 
of expert opinion to predict future population dynamics. 
In the last 15–20 years, the simple extrapolation methods have rapidly 
evolved into more complex stochastic methods. These methods rely on statistical 
techniques and algorithms used to analyse a matrix of disaggregated data, divided by 
age, sex and/or other variables (Booth and Tickle 2008; Cairns, Blake, Dowd, 
Coughlane, Epsteine, Ong, and Balevich 2009; Cairns, Blake, Dowd, Coughlane, 
Epsteine and Khalaf-Allah 2011).  
The study of mortality led to the development of graduation models that have 
been used to soften crude mortality rates and to analyse the behaviour of mortality. 
With the emergence of new statistical methods, the analysis of mortality was 
revolutionised.  Among these the Poisson models were developed, which estimate the 
number of deaths in each age given the number of people exposed to risk. Among the 
stochastic models used to adjust mortality, the most representative are the CMI model 
(Continuous Mortality Investigation), the Lee-Carter model and its extensions 
(Renshaw-Haberman, Age-Period-Cohort, CBD, M7 and Plat).  
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For example, the Lee and Carter, (1992) and its variants and extensions 
estimate the age pattern of mortality using time series methods based on a matrix 
decomposition of mortality data, assuming the dynamic nature of mortality trends over 
time is ruled by a single parameter (Andreozzi, Blacona and  Arnesi 2011). Although 
originally developed for US mortality data, the Lee-Carter model is now the “leading” 
long–term forecasting model internationally (Kan 2012), and is used to analyse 
mortality in different countries, from different causes, and over different time periods 
(Girosi and King 2007). It has become a dominant base model to which extensions or 
modifications are added, with differing levels of success (Wang 2007).  
Even though current studies in the literature prove that is a continuous 
improvement in mortality rates, with child mortality rapidly decreasing, in particular 
some specialists consider it unreasonable to expect this rate of improvement to 
continue ( Lewis and McCormick 2012). These stochastic methods require minimal 
subjective input and are particularly useful in that they include a measure of 
uncertainty in their extrapolations, allowing the forecast of probability distributions of 
mortality, rather than a single point forecast for which the degree of uncertainty cannot 
be quantified. 
The research in this thesis is an extension of the work conducted by Kul and 
Sucu (2015), they compared eight stochastic models that applied on Turkish mortality 
data for both male and female, aged 5 to 89 over the period 1980 to 2012. The mortality 
models compared were the Lee-Carter model (M1), the Renshaw-Haberman model 
(M2), the APC model (M3), the Renshaw-Haberman model (M4), the CBD model 
(M5), the M6 model, the M7 model and the Plat model (M8). The criteria for model 
selection were the Bayesian Information Criterion (BlC), the Mean Absolute 
Percentage Error (MAPE) and unexplained variance. Kul and Sucu found that the Lee-
Carter model gave a poor fit; in contrast, Renshaw-Haberman was the best performing 
model. The data considered deaths and exposed numbers of were grouped into five age 
bands to fit mortality rates by using Lifemetrics R-code software. Moreover, ARIMA 
models were used to forecast the general index for both time and cohort period, which 
was used for life expectancy forecasting from 2013 to 2030. Obviously, they have 
made a commendable effort in terms of a number of models and tried to evaluate them 
and show the best. Nevertheless, their analysis did not focus on the age stratification 
and time factor, which necessarily does not give accurate results. While the current 
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study compared the six stochastic models—the Lee-Carter model, the Renshaw-
Haberman model, the APC model, the CBD model, the M7 model and the Plat 
model—with particular reference to Australian mortality data; both the modelling 
period and ages modelling to evaluating these models were taken into consideration. 
The analysis is performed on data from Australia for both sexes over three different 
scenarios and for four look back windows and five look forward windows were 
adjusted to prediction of mortality rates for the years 2007 to 2011. Furthermore, the 
models are evaluated based on three common statistical model selection criteria and a 
diagnostic plot in the form of heat maps. Mortality models were fitted and evaluated 
using the StMoMo package in R. The mortality rates were forecasted for a period of 
50 years, from 2012 to 2061 for both sexes. The accuracy of mortality rates forecasting 
has improved when using age stratification, which used several stochastic mortality 
models instead of a single model. 
1.2 Objective 
The main objective of this thesis is to analyse female and male mortality in Australia 
so as to accurately forecast mortality rates and life expectancy. Thus, six stochastic 
mortality models are applied to the Australian data between 1961 and 2011 (namely 
the Lee-Carter model (LC or M1), the Renshaw and Haberman model (RH or M2), the 
Age-Period-Cohort model (APC or M3), The Cairns-Blake-Dowd models (CBD or 
M5 and M7) and the PLAT model (M8)). A comparison is then made between the six 
mortality models using different selection criteria (Root Mean Square Error, Bayesian 
Information Criterion and Akaike Information Criterion) in order to choose the best-
fitted model to be used for mortality and life expectancy forecasting in Australia.  
Regarding the investigation and forecasting of mortality rates in Australia, a 
review of the literature shows that only a few studies have been carried out to model 
and project mortality. For example, Booth, Maindonald and Smith (2001) apply the 
Lee-Carter model to the Australian data to show that the assumptions of the model are 
not always met because of age-time interactions. More recently, Booth and Tickle 
(2008) use the Lee-Carter model on Australian data for the period 1968–2000 to 
forecast mortality to 2031. Furthermore, they compare the results obtained with 
official projections.  
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Given the lack of recent mortality studies in Australia, this thesis intends to 
achieve the following objectives: 
 To present and explore different models for mortality estimation and forecasting; 
 To investigate and estimate six models (the original Lee-Carter model and its 
extensions) that employ extrapolative class of stochastic mortality models; 
 To compare and evaluate the six stochastic models and to use different model 
selection criteria in order to decide which model is the best to forecast Australian 
mortality rates and life expectancy; 
 To calculate the mortality rates for the Australian population (females and males), 
for which the methodology necessary for the mortality rates construction will be 
described and implemented; 
 To check if age, period and cohort patterns prove to be important for clarifying 
mortality patterns; 
 To find optimal age/time stratification of data for forecasting mortality rates and 
life expectancy; 
 To use the best-fitted model to project mortality rates and life expectancy for 
Australian females and males for the next 50 years. 
1.3 Significance of research 
The research conducted in this thesis offers significant potential contributions to 
accurate forecasts of mortality levels in Australia. The purpose of this thesis is to 
explore mortality patterns in Australia and to analyse and predict mortality rates and 
life expectancy. These contributions are essential in selecting accurate models on 
which to base future forecasts. The comparison of the six mortality models (starting 
with the original Lee-Carter model and ending with one of its most recent extensions), 
with the purpose of selecting the best model for Australian mortality and life-
expectancy forecast represent own contributions highlighting the originality and 
significance of the research.  
The thesis is structured over five chapters, starting with the presentation of 
conceptual and theoretical aspects and continuing to merge with empirical elements that 
allow testing the applicability of the six mortality models on Australian mortality data.  
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Chapter 2 — Literature Review — gives a historical development of the 
mortality models in the research literature. This chapter provides an overview of 
previous research on mortality and life-expectancy forecasting, focusing on the Lee-
Carter model and its extensions. Also, the purpose of this chapter is to introduce the 
framework for the application of the six stochastic mortality models that represent the 
main focus of the research conducted in this thesis. 
Chapter 3 — Analysis of Australian Female Mortality — compares the results 
of the six mortality models estimated using Australia female data. This chapter 
explores mortality patterns in Australia over the period 1961– 2061, analyses and 
predicts female mortality rates using the best-fitted model (selected using four different 
selection criteria: the RMSE, the AIC, the BIC and heat-maps of residual plots) and 
detects and models the eventual presence of cohort effects in mortality patterns. The 
purpose is to predict mortality rates and compute life expectancy for the next 50 years. 
Similarly, Chapter 4 — Analysis of Australian Male Mortality — compares 
the results of the six mortality models applied to the Australian male data. This is done 
by using four different selection criteria for model selection (the RMSE, the AIC, the 
BIC and heat-maps of residual plots). The purpose is to select the best model that can be 
used to predict mortality rates and life expectancy for the next 50 years.  
Finally, Chapter 5 — Summary, Conclusions and Recommendations — 
concludes and summarises the work and the most important results obtained, presents 
the main contributions of the thesis focusing on the original elements and results and 
describes some limitations and directions for future research. 
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Chapter 2 Literature Review 
2.1 Introduction 
In recent years, the human population has experienced a vast improvement in the 
quality of life and health, owing to a variety of scientific, technological, environmental 
and socio-economic factors (Aro and Pennanen 2011). Life expectancies in developed 
countries have gone up from 25 to 40 years at the beginning of the 20th century 
(Maddison 2001) to about 70 years by 1960 (Edwards and Tuljapurkar 2005). 
Longevity has increased across the industrial world since then at an estimated annual 
rate of 0.2 years (White 2002).  
This improvement in mortality has varied across different countries and 
demographics (Tuljapurkar and Boe 1998) as well as age groups (Keilman 2008). 
Behavioural differences, such as smoking has been identified as an important factor 
influencing mortality rates (Gjonça, Tomassini and Vaupel 1999; Pampel 2002). 
Improvement in female mortality rates (Oeppen and Vaupel 2002), reduction in infant 
mortality since World War II (Cheung, Robins, Tu and Caselli 2005) due to 
immunization, control of infectious disease and better health care for the aged, are 
some of the drivers of improvement in life expectancies (Booth, Maindonald and 
Smith 2002).  
The unprecedented increase in longevity and lower mortality rates have posed 
an unprecedented risk on financial institutions (Wang, Huang, Yang and Tsai 2010). 
To cope with the demands of the growing elderly pensionable population, insurance 
and pension providers rely on higher capital stores (Plat 2011). Learning from past 
errors in forecasting longevity, financial institutions continue to develop more 
complex forecasting models, with the goal of selecting at the model that provides the 
least uncertainty and best estimate (Haberman and Renshaw 1996). A variety of 
unrelated, unpredictable events governing the improvement of mortality rates have 
necessitated the development of stochastic models to quantitatively analyse these 
improvements with a high degree of confidence (Cairns et al. 2009). Falling interest 
rates complicate the issue of rising longevity, which together have led to increased 
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uncertainty and error in financial institutions with respect to insurance and long-term 
pensions (Sweeting 2008).  
Mortality studies in the UK have shown considerable improvements in 
mortality rates of 65–year-old males after 1960, whereas the same estimations for 25–
year-olds showed improvements before 1960 but levelled off in the decades that 
followed (Dunnell 2007). Mortality rates have decreased significantly compared with 
the elderly. The pattern of decline or the curve of mortality rates varies from year to 
year due to prevailing conditions during that period, such as flu epidemics, heat waves, 
or other such underlying environmental factors (Cairns, Blake and Dowd 2008). This 
fluctuation of mortality rates leads to considerable uncertainty and volatility in 
forecasting for future generations.  
Traditional risk management approaches used to calculate mortality and life 
expectancy rates may lead to biased results, introducing errors into calculations. 
Losses due to miscalculation of mortality rates coupled with volatility in financial 
markets call for an increased level of precision in predicting mortality rates as well as 
determining uncertainties associated with such projections (Melnikov and Romaniuk 
2006). When calculating mortality and life expectancy rates using direct or indirect 
methods of age adjustment, a random error may be a significant issue. To solve the 
problem of error in calculation, researchers quantified the errors and calculated 
confidence intervals around the measured mortality and life expectancy rates 
(Anderson  and Rosenberg 1998). Furthermore, over the years many statistical models 
have been developed to address uncertainties associated with changing mortality rates, 
each with their pros and cons. 
2.1.1 Statistical mortality models 
Methods for forecasting uncertainties may be static or dynamic, as suggested by 
Tuljapurkar (1997). Static methods involve making assumptions based on subjective 
determinations, whereas dynamic methods pertain to stochastic models fitted to 
historical data (Li 2007: p.2). The latter is more sensitive to parameter changes and 
hence are more highly valued in actuarial practice (Continuous Mortality Investigation 
Bureau 2004). 
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According to Blake (2013), stochastic models may be classified as process-
based, explanatory and extrapolative projections. Process-based models are highly 
subjective based on cause-and-effect relationships. Explanatory models are based on 
regressive analysis of exogenous causes, such as correlating health and income 
indicators with mortality rate. These models are again based on assumptions and 
hypothesis testing (Blake 2013). These models fit each age/period terms and do not 
capture more complex parameters such as the generational influences or cohorts. Since 
the mortality rates are influenced by multiple stochastic factors, complex models that 
fit multiple parameters are needed to optimize estimations (Aro and Pennan 2011). 
Extrapolatory models use parametric or none-parametric factors tailored for complex 
datasets spanning multiple ages and periods, designed to produce accurate forecasts 
which capture complex phenomena. These models are of two types: none-parametric 
models or the Lee-Carter class of models; and parametric models, or the Cairns-Blake-
Dowd class of models (Blake 2013).   
Stochastic models are two-dimensional designed to predict mortality rates by 
age and time. Most stochastic models identify three parameters in mortality data. These 
parameters are the age effect, time effect and the birth cohort (Kul and Sucu 2015). 
2.1.2 The cohort effect 
A cohort effect is a difference in health and life patterns because of varying 
environmental exposures and societal experiences of different cohorts (Willets 2004).  
Changing trends in mortality may be associated with several factors. A wide 
variety of covariates may be included in a dataset ranging from gender, education, 
ethnicity, occupation, lifestyle indicators such as smoker or non-smoker status and 
lifestyle indicators such as smoker or non-smoker status. However, computation of 
several covariates is complex and does not necessarily contribute to the forecast 
(Cairns et al. 2011).  
Mortality rates have been linked to specific generations or year of birth 
(Richards, Kirkby and Currie 2006). The birth cohort, which refers to people born in 
the same year, is most commonly added to the age and period effects in most stochastic 
mortality models. The birth cohort may be seen as an index of barriers and resources 
that affect health and mortality (Keyes and Li 2010). The birth cohort satisfies the 
 10 
assumption that people born in the same year or time frame experience similar health 
effects which in turn affects their mortality rates, as evidenced in the UK in studies 
conducted by the Continuous Mortality Investigation (2002) and Willets (2004). 
Investigations showed highly significant improvements in mortality rates in 
individuals born between 1920 and 1940 in the UK and other European countries, 
largely attributed to the introduction of healthcare and a drop in the number of smokers 
(Hunt and Villegas 2015).  
The cohort effect has been adopted from various areas of research including 
epidemiology and social sciences (Willets 2004). The year of birth significantly affects 
mortality rate by a combination of factors. Richards et al. (2006) discovered that the 
maximum improvement in mortality rates in England and Wales were experienced by 
people born in or around 1930. Willets (2004) argued that the rapid decrease in mortality 
rates for the cohort born between 1925–1944 compared to those born a decade earlier 
could be attributed to the adverse conditions of war suffered by the previous generation. 
Cigarette distribution was the highest during the war and declined steadily after 1960; 
this would be reflected in the improved mortality rates of the cohort born after 1944. The 
cohort effect at birth continues into old age thus impacting mortality rates for higher age 
groups. The longevity of the birth cohort born between 1920 and 1940 is highly 
significant in the present day, as a large number of pensioners drawing from financial 
reserves over an unpredictably long period of time would impose unprecedented costs 
on governments, financial institutions, and healthcare organisations (Hunt and Villegas 
2015). The presence of a cohort effect in a dataset may be manifested as a marked 
distortion of mortality curves (Cairns et al. 2009). 
2.2 Criteria for comparing stochastic models 
There is an attempt to critically examine six such models that empirically explain 
changing mortality rates concerning actuarial risk management. 
The models reviewed in the current thesis, are the Lee-Carter one-factor 
model, 1992 (M1), the Renshaw-Haberman extension, 2006 (M2), the age-period-
cohort simplification, 2006 (M3), the Cairns-Baird-Dowd two-factor model, 2006b 
(M5), the M7 generalisation of CBD (2007) and Plat’s proposed model (M8) which 
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incorporating the strengths of the existing models while eliminating their weaknesses 
(Plat 2009). 
Typically, statistical models on mortality are assessed on their efficiency to 
calculate longevity and mortality risks (Plat 2009).  Since all mathematical and 
statistical models are only an approximation of reality (Cairns et al. 2011), they need 
to be evaluated on the plausibility of their predictions. Models that balance parsimony 
with flexibility are most preferred (Danesi, Haberman and Millossovich 2015).  
A parsimonious or simple, well-specified model is certainly preferred to an 
unnecessary complex one. Quantitative criteria relate to the consistency of the forecast 
with historic data and robustness in relation to current data (Cairns et al. 2009). The 
goodness of fit for a dataset is estimated by the log-likelihood function. Bayes 
information criterion, (Dowd, Cairns, Blake, Coughlan, Epstein and Khalaf-Allah 
2010a: p.2), Akaike information criterion (AIC), and the log-likelihood ratio test 
(LRT) are some of the model selection criteria suggested (Li, Hardy and Tan 2009).   
The Akaike information criterion is:  
 
𝐴𝐼𝐶𝑖 = 𝐿(∅̂𝑖) − 𝑛𝑖  (2.1) 
The Bayes information criterion (BIC) is:  
 
𝐵𝐼𝐶𝑖 = 𝐿(∅̂𝑖) − 1/2 𝑛𝑖𝑙𝑛𝑁 (2.2) 
ni = number of parameters estimated in the model. 
N= number of observations  
𝐿(∅̂𝑖) = max. log likelihood.    
Both AIC and BIC are measures of fit and parsimony. The model that gives 
the minimum AIC or BIC is selected (Biffi and Clemente 2014). BIC penalizes 
complexity more stringently so it is normally used to select for parsimony (Burnham 
and Anderson 2004). 
According to Cairns et al. (2011), the qualitative criteria examined in 
stochastic mortality models include (a) biological reasonableness, (b) robustness of 
parameter estimates for extensions in data period and age range,  (c) stringency or 
parsimony,  (d) the robustness of forecasting realistic uncertainties, (e) incorporation 
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of cohort effects, (f) the ease with which the model is interpreted and translated into 
practical solutions, (g) the capacity to define parameters, generate sample paths and 
projection intervals so as to allow assessment of uncertainties for future cash flows. 
(h) It is also important for a model to produce, non-trivial correlations between relevant 
age ranges  
These six models were selected based on their suitability for projections on a 
more aged population, as seen by historical data forecasts (Cairns et al. 2011).  
2.3 Basic notations  
Stochastic models use either 𝑚𝑥,𝑡 , which is the crude death rate (Dowd et al. 2010a), 
also referred to as the central mortality rate (Plat 2009), or 𝑞𝑥,𝑡 , which is the initial 
mortality rate, for year t for age x.  










(𝑑𝑒𝑎𝑡ℎ𝑠 𝑑𝑢𝑟𝑖𝑛𝑔 𝑐𝑎𝑙𝑒𝑛𝑑𝑎𝑟 𝑦𝑒𝑎𝑟 𝑡 𝑎𝑡 𝑎𝑔𝑒 𝑥 𝑙𝑎𝑠𝑡 𝑏𝑖𝑟𝑡ℎ𝑑𝑎𝑦)
𝑎𝑣𝑒𝑟𝑎𝑔𝑒 𝑝𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛 𝑑𝑢𝑟𝑖𝑛𝑔 𝑐𝑎𝑙𝑒𝑛𝑑𝑎𝑟 𝑦𝑒𝑎𝑟 𝑡 𝑎𝑡 𝑎𝑔𝑒 𝑥 𝑙𝑎𝑠𝑡 𝑏𝑖𝑟𝑡ℎ𝑑𝑎𝑦
 (2.4) 
Simply stated, the central mortality rate is the annual number of deaths 
divided by the mid-year population (Tuljapurkar, Li, Nan and Boe 2000), the latter 
representing the exposure to death during calendar year t at age x last birthday (Kul 
and Sucu 2015). The data for this estimation is readily available in national statistics 
offices (Office for National Statistics 2016).  
Uncertainties associated with mortality risk may be either unsystematic or 
systematic. The unsystematic uncertainties arise due to the randomness of the number of 
deaths which is relatively small for higher populations. On the other hand, systematic 
uncertainties affect the entire population which is significant in predicting future trends 
(Cairns et al. 2008). The purpose of mortality model is to account for these uncertainties 
or risks in future forecasts to ensure appropriate cash flows. This includes short-term risks 
of catastrophes and epidemic (Cairns, Blake and Dowd 2006b). 
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The probability that an individual aged x will die in the current year t, is 
referred to as the initial mortality rate (Plat 2009) or the true, unobserved mortality rate 
(Cairns et al. 2008), defined by the equation:  
 
𝑞(𝑥,𝑡) = 1 − 𝑒
−𝑚(𝑥,𝑡) (2.5) 
Stochastic models assume that the number of deaths follows a Poisson distribution 
which can be approximated to a normal distribution for large populations (Dowd et al. 
2010a). This is important for determining mortality residuals and percent error, implying: 
𝐷(𝑥,t) ∼  𝑃𝑜𝑖𝑠𝑠𝑜𝑛 (𝐸(𝑥,t)𝑚(𝑥,t))  (2.6) 




(1 + 0.5𝑚 (𝑥,𝑡))
 (2.7) 
2.4 Review of mortality rates 
2.4.1 Review of mortality rates by gender: 
Variation in mortality rates between the sexes has been a subject of considerable 
interest for more than two hundred years (Gjonça, Tomassini, Toson and Smallwood 
2005). Paleo-demographers, who derive their statistical data from examining 
prehistoric skeletal remains, contend that these differences were linked to the growth 
of agriculture in early societies (Bocquet-Appel and Masset 1996). As a rough 
estimate, this period is presumed to be after the fall of the Roman Empire in the early 
middle ages (Boldsen and Paine 1995). It is now widely accepted that women live 
longer than men in both wealthy as well as impoverished countries (Poulain 2012). 
The reason for this difference has been attributed to a range of biological, cultural, 
economic and social causes (Robsen 2015).  
Among the biological causes one of the main factors believed to influence 
life-span, is the female-specific hormone, oestrogen (Kirkwood 2010). This hormone 
is known to protect the brain and central nervous system from degenerative disorders, 
owing to its ability to remove fat deposits that contribute to plaque formation in the 
brain tissue. By the same mechanism, it protects women against ischemic heart and 
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coronary disease (Waldron 1993). Post-menopausal women are more at risk of heart 
attacks than younger women. However, the incidence of heart attacks in 
postmenopausal women is lower than that of men in the same age group. Lowered 
testosterone levels have been associated with higher mortality (Poulain 2012). High 
testosterone levels exacerbate the risk of cardiovascular failure in men who have a 
history of cigarette smoking and high cholesterol levels (Webb, McNeill, Hayward, 
De Zeigler and Collins 1999).  
The presence of two X chromosomes in females is another biological factor 
contributing to their increased longevity. Since men have only one X chromosome, 
any damage to the genes on the X chromosome is detrimental, whereas in women, it 
has been postulated that damage to one X chromosome is compensated for by the 
second X chromosome (Christensen, Kristiansen, Hagen-Larsen, Skytthe, Bathum, 
Jeune, Andersen-Ranberg, Vaupel and Ørstavik 2000).  
Biological factors may also affect behaviour, as high testosterone levels lead 
to risky and aggressive behaviours (Archer 1994). Cultural factors tend to put men at 
a higher risk than females (Reddy 1999). Men are more frequently involved in 
occupations such as mining and heavy engineering. These occupations, while being 
physically perilous, also tend to impact on health, as they often cause mental stress. 
Increased stress and insecurity lead to unhealthy behaviours such as cigarette smoking 
and excessive alcohol consumption. Furthermore, women are known to be more 
conscious of seeking medical advice for health problems and have a healthier diet. 
They are, in general, less likely to indulge in dangerous behaviour and insecure 
lifestyle (Waldron 1993).  
In a comparative study on gender-based mortality in three developed western 
countries over the last 150 years, Wisser and Vaupel (2014) showed that the difference 
in mortality rates (DMR) between the two sexes has been increasing from 1860, with 
an excess of male deaths across most age groups. The exception was between the ages 
5–15 before 1930, where a distinct female disadvantage is seen. The disadvantage has 
been attributed to poor housing and higher degree of frailty among young girls, 
rendering them more susceptible to infectious disease, most notably tuberculosis. It 
has been argued that the excess in feminine mortality during this period is a 
consequence of sexual discrimination which deprived girls of education, medical aid, 
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good nutrition and hygiene (Gjonça et al. 2005). Higher maternal mortality was 
another factor contributing to the female disadvantage before 1930 (McNay, 
Humphries, and Klasen 2005).  
Following the two world wars, female mortality rates declined over that of 
their male counterparts. Male mortality rates were highest for ages between 18–25 
years. There was also a peak at around the age of 60, owing to a rise in cardiovascular 
diseases (CVD). This trend continued after the war, the leading causes of deaths in 
younger males being traffic accidents and CVD continuing to be the main killer in 
older age groups (Guralnik, Balfour and Volpato 2000). However, since 1980, the 
difference in mortality rates between the sexes has been narrowing largely due to 
improved treatments and preventative methods for CVD. This trend was similar in all 
countries studied. (Wisser and Vaupel 2014).  
Gender differences in mortality rates vary by country, with a definite 
advantage in life-expectancy enjoyed by females in the developed world (Daw 1961). 
While this is most prominent in developed countries. For instance, in Japan, life 
expectancy for women is 86 years and 79 years for men, giving the former a 7 years 
advantage (Yin 2016). However, in India, the life expectancy for women is 64 years, 
while that of their male counterparts is 63 years (Sulaja 2016).  
Following the trend in other developed countries, the current figure for life-
expectancy in Australia is 84.4 years on average for females and 80.3 years for males, 
with a female advantage of 4.1 years. In 1998, the female advantage was 5.4 years, 
when life expectancy for females was 82 years and 76.6 years for males. As a corollary, 
the standardised death rate was lower in females at 0.46% as compared to 0.64% for 
males in 2012 to 2014 (Australian Bureau of Statistics 2016).  
As opposed to these figures, the current life expectancy for indigenous 
Australian females is estimated at 73.7 years and 69.1 years for males (Steering 
Committee for the Review of Government Service Provision 2014). 
In Australia, dangerous life-styles and behaviour are a cause of rampant 
mortality among teenagers, young adults, and men below the age of forty-five (Wisser 
and Vaupel 2014).  However, despite disturbing patterns of reckless consumption and 
behaviour, Australia currently has the sixth highest life-span expectancy in the world, 
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as documented by the Australian Institute of Health and Welfare (World Health 
Organization 2016). 
In the 1889–1890 Australian census, males average were expected to live up to 
the age of 47.2 years and females on average, until the age of 50.8 years. In the early 
1900s, the major cause of death was an infectious disease, which peaked in 1919 with 
the pandemic of Spanish influenza, but declined drastically thereafter, following the 
advent of vaccines and antibiotics. Infectious disease was replaced by cardio-and 
cerebrovascular disorders as the leading cause of fatality among the Australian 
population. Deaths due to heart disease rose steadily during 1960–70 but has been 
continuously declining since.  With rapid advances in scientific knowledge, coupled 
with astonishing developments in medicine and technology, the life expectancy for both 
males and females rose sharply over the next several decades (Australian Institute of 
Health and welfare 2016).  
The highest incidence of deaths for the ages 15–44 is by suicide, drugs and 
motor-vehicle accidents, as reported by the Australian Bureau of Statistics (ABS 
2016). Coronary heart disease is the biggest killer in males aged 45–95 years. In 
females, the causes of mortality for the same cohort are more varied. Breast cancer is 
the primary killer of the ages 44–65 years, and lung cancer dominates ages 65–79. 
Deaths due to lung cancer show a rising trend in women over the last century. This has 
been attributed to changing lifestyles including increased cigarette smoking. Coronary 
heart disease is the main cause of fatality after 79 years in females. While mortality 
due to heart disease is on the decline, that due to Alzheimer’s disease and dementia is 
on the rise (Evershed 2016).  
In general, death rates have continuously fallen from 1200 per 100,000 males, 
and approximately 900 per 100000 females in 1907, to approximately 660 per 100,000 
males and 620 per 100,000 females in 2013 (Evershed 2016).  
Sixty percent of women survived beyond the age of 85 years in 2012–2014, 
while only 45% of men in the same cohort survived to the same age. Yet the 
pensionable age for both genders remains the same. This is currently at 60 years for 
those born before 1952, and 65 years, 6 months for those born in the following 6 
months, increasing by a factor of 6 months for every 2–year cohort, reaching 67 years 
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by 2023 when those born January 1957 are eligible to access their age pensions 
(Department of Human Services 2016).  
The narrowing gap in life expectancies between men and women may justify 
their equality in accessing age pensions. However, with changing trends, it would be 
prudent to examine the changing mortality rates within specific cohorts, to more 
accurately predict the period of financial dependence of female pensioners, and thereby 
disburse funds more equitably (Espejo and Montero 2006). Increased lifespans among 
women would require planning for their health, social as well as economic welfare, 
based on realistic forecasts (Booth, Hyndman, Tickle and De Jong 2006). Failure to do 
so could lead to an excessive burden on the country’s financial system causing a wide 
range of repercussions through the economy (Alho, Jensen and Lassila 2008: p11).  
In the actual social and demographic context, the analysis, forecasting, 
modelling and monitoring of the mortality rates are of fundamental importance. For 
example, Birdsall, Kelley and Sinding (2001) in the book called “Population matters: 
demographic change, economic growth, and poverty in the developing world” argue 
that demographic forecasting represents a fundamental tool in developing programs 
and strategies for the economic and social development of a country. The high 
dimensionality of the data represents a problem in the process of mortality forecasting. 
In order to deal with this, researchers developed several models and methodologies. 
2.4.2 Review of mortality models: 
2.4.2.1 The Lee-Carter model (LC or M1) 
The stochastic mortality model of Lee and Carter (1992) is the primary stochastic 
model widely used across several countries including the US and Australia (Booth et 
al. 2006). The model, which is taken as a point of reference for development of more 
complex models is basically extrapolative and incorporates demographic 
considerations of mortality with an autoregressive integrated moving average 
(ARIMA) time series model analysis and is best suited for long-term forecasting, 
although variations have been made to fit in short to medium-term projections (Booth 
et al. 2006). The method is simple and robust for analysis of linear trends of death rates 
by age-specific calculations (Renshaw and Haberman 2003).  
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The Lee-Carter model is defined as: 
 
𝑙𝑛 (𝑚𝑥,𝑡) =  𝑎𝑥 + 𝑏𝑥 𝑘𝑡 + 𝜀𝑥,𝑡  (2.8) 
where 𝑎𝑥  and 𝑏𝑥  are age specific constants reflecting age related effects; 𝑘𝑥 is the period 
effect or mortality index reflecting period related effects (Cairns et al. 2009; Booth et al. 
2006). The error term 𝜀𝑥,𝑡  is the residual at age x and time t (Lee and Carter 1992).  
The mortality rate is a function of age and calendar year as exemplified by 
the model the dominant parameter being the mortality index k for the calendar year t.  
The model weighs heavily on past trends; the age-specific constant 𝑎𝑥 is the shape 
of the mortality curve across ages, calculated as a function of average central mortality rates 
over time (mean ln (𝑚𝑥,𝑡))  and 𝑏𝑥 is the age-specific relative rate of mortality change 
attributable to social and historical factors (Lee and Carter 1992). This may be positive or 
negative depending on the age group. The model is constrained by normalising  𝑏𝑥  to sum 
to unity (∑ 𝑏𝑥𝑥 = 1) and 𝑘𝑡  sum to zero (∑ 𝑘𝑡𝑡 = 0) (Booth et al. 2006). 
The period effect 𝑘𝑡 is calculated as: 
 
𝑘𝑡  = 𝑘𝑡−1 + 𝑑 + 𝑒𝑡 (2.9) 
where d is the mean annual variation in 𝑘t and 𝑒𝑡 denotes uncorrelated error 
(Booth et al. 2006).  
The period effect may be calculated either as a random walk or an ARIMA 
process (Continuous Mortality Investigation 2007).  
The Lee-Carter model forecasts mortality rates by age, using extrapolated 
values of 𝑘𝑡 and fixed values of age related measures 𝑎𝑥 and 𝑏𝑥 . When 𝑘𝑡varies linearly 
with time, age-specific variation in mortality takes place at a constant exponential rate. 
When 𝑘𝑡tends to negative infinity the age-specific rates tend to zero. The model is robust 
in that it excludes the occurrence of negative mortality rates (Lee and Carter 1992).  
The model permits the construction of period-specific life tables and age-specific 
mortality tables, using the single parameter k as the index of mortality. Further, the model 
uses variations in a single parameter to forecast mortality trends, fulfilling the criterion of 
parsimony. Uncertainties in measurements of mortality rates are computed by: 
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𝑙𝑛 (𝑚𝑥,𝑡+𝑠) =  (?̂?𝑥 + 𝛼𝑥) + (?̂?𝑡+𝑠 + 𝑢𝑡+𝑠)(?̂?𝑥 + 𝛽𝑥) + 𝜀𝑥,𝑡+𝑠, (2.10) 
where 𝛼𝑥 and  𝛽𝑥 are errors in calculating 𝑎𝑥  and 𝑏𝑥 respectively and 𝑢𝑡+𝑠 is the error in 
forecasting k for a period of s from starting point t.  
The goodness of fit is seen to decrease in ages where the mortality rates are 
low and underestimates death rates for lower ages (Lee and Miller 2001: pp 537–549). 
The assumptions in the model are transparent and calculations are plausible. 
It is possible to estimate parameters in relatively accessible computer software such as 
Excel and R (Gustafsson 2011). 
Incorporating data for the period 1950–1994 for ages ranging from 0–105, 
Tuljapurkar et al. (2000) found that mortality rates in each of the G7 countries (Canada, 
France, Germany, Italy, Japan, UK, US) declined exponentially at a constant rate, the 
value of 𝑘𝑡 following a linear trend. They also demonstrated that the decline in 
mortality for each age group is dependent on the age factor 𝑏𝑥  and is a product of 
𝑘𝑡 and 𝑏𝑥 .   
It is therefore feasible to forecast life-expectancy at birth in the G7 countries 
using the long-term linear decline of mortality index 𝑘𝑡  (Tuljapurkar et al. 2000). 
Adjusting the value of 𝑘𝑡 to account for historical deaths in each year, and 
incorporating it into a stochastic model of decline:  
 
?̂?(𝑡+1) =  ?̂?(𝑡) − 𝑧 + 𝜖𝑡 (2.6) 
where z is the rate of decline of mortality and 𝜖𝑡 denotes background stochastic 
disturbances (Tuljapurkar et al. 2000).  
Using the adjusted value of 𝑘𝑡, decline in mortality rate z for different 
countries was calculated for the period 1995 to 2050, and ranged from 0.3 to 0.5 per 
year in North America and Europe to a high of 0.8 per year in Japan (Tuljapurkar et 
al. 2000). This rapid fall in mortality has been attributed to immunization and better 
health care, but is expected to slow down or stop with novel causes of death that 
balance out the progressive factors promoting longevity (Tuljapurkar et al. 2000). One 
of these factors suggested by Lee and Carter (1992) is the emergence of infectious 
diseases such as AIDS. However, with successful antiretroviral therapies, the rates are 
likely to continue declining.  
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Plat (2009) and Cairns et al. (2009) have pointed out many weaknesses in the 
Lee-Carter model. This being a single factor model has a trivial correlation structure 
in that the mortality improvements across all ages appears perfectly correlated. It is 
potentially inflexible with respect to age (Renshaw and Haberman 2003). As the 
improvement rate (𝑏𝑥 ) decreases with increasing age, life-expectancies at higher ages 
are likely to be underestimated (Plat 2009).  
Furthermore, since it does not take into consideration cohort effect, it may not 
be consistent with historical trends in countries with a significant cohort effect, as 
evidenced by Turkish studies (Kul and Sucu 2015).  
Another observation is that the model suffers from being too precise at higher 
ages, suggesting that uncertainties are underestimated (Cairns et al. 2011). The model is 
not suitable for outliers, such as increased deaths resulting from the flu of 1918 or 
increased suicide rates or HIV deaths in more recent times (Renshaw and Haberman 
2003).  The Lee-Carter model is preferred when assessing linear trends of historical data 
and when a subjective judgement of the data is not needed (Di Cesar and Murphy 2009).  
2.4.2.2  The Renshaw-Haberman model (RH or M2) 
The inflexibility of the Lee-Carter model was exemplified in mortality forecasting 
using data from England and Wales for the period 1950–1998 (Renshaw and 
Haberman 2003). Importantly, raw data clearly showed the spike in male mortality in 
the age group 20–39 from the last quarter of the 20th century but this was not captured 
by the Lee-Carter model.  
To provide for such anomalous but significant data, Renshaw and Haberman 
(2003) the Lee-Carter model modified to include the cohort or birth-time effect. This 
was the first model developed incorporating the cohort effect. This is a multifactor 
model defined as: 
 




𝛾𝑡−𝑥 + 𝜀𝑥,𝑡  (2.7) 
As with the Lee-Carter model, 𝑎𝑥 ,  𝑏𝑥
(1)
  and 𝑏𝑥
(0)
are age parameters and 𝑘𝑡is 
the period effect or mortality index at time t.  The random cohort effect 𝛾𝑡−𝑥 is a 
function of the year of birth, t–x, derived as: 
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𝛾𝑡−𝑥 =  𝛾𝑐 =  𝛾𝑐−1 +  𝜇𝛾 + 𝛼𝛾  ( 𝛾𝑐−1 − 𝛾𝑐−2 − 𝜇𝛾) +  ∅ 𝑍𝛾(𝑐) (2.8) 
where 𝜇𝛾  and  𝛼𝛾 are drifts, ∅ denotes an unknown parameter class, and 𝑍𝛾(𝑐) is a normal 
innovation independent of the period effect (Kul and Sucu 2015).  
Estimation of the cohort effect 𝛾𝑡−𝑥  is facilitated by an iterative scheme based 
on the Newton-Raphson algorithm (Cairns et al. 2011). The underlying assumption of 
the model is that the cohort effect 𝛾𝑡−𝑥  is independent of the period effect 𝑘𝑡. 





 to unity.  
When using the model for forecasting at a specific time, intervals are chosen 
to check for cohort effects for specific time periods. Estimation of parameters can be 
performed via available packages in R (Hunt and Villegas (2015); Spedicato, Kang, 
Yalamanchi and Yadav (2016)). Fixed age effects are computed using SVD for the 
least square solution (Gustaffsson 2011).   
The RH model had some improvements over the LC model, the most apparent 
of which was that the standardised residuals were independent of the year of birth for 
certain periods, unlike the LC model where a high dependency was seen for certain 
periods; in other words, the error in the LC model was period related and this is 
probably suggestive of a cohort effect (Cairns et al. 2008). 
The RH model provides a good fit for historical data from countries with 
significant cohort effect observed in the past (Plat 2009). In a recent Turkish study on 
mortality rates (Kul and  Sucu 2015), the Renshaw-Haberman model gave a better fit 
to data for both males and females as compared to the Lee-Carter model, using the 
Bayes information criterion (BIC) for comparison. In another study involving 
mortality data for males aged 64–89 for the period 1961 and 2007 from England, 
Wales and the US, the Renshaw-Haberman model had the highest BIC ranking in 
terms of goodness of fit (Dowd et al. 2010a). Similar ranking was seen for Turkish 
data (Kul and Sucu 2015). 
However, Hunt and Villegas (2015) argue that the main drawback of the 
model is its lack of robustness to changes in data. In some situations, the identifiability 
is inherent in the model but not serious. For example, in mixture models the lack of 
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identifiability relates to re-labelling the components, but this still leads to the same 
parameter estimates within the re-labelled components and in general there are no 
issues with convergence. These computational flows are related to the identifiability 
problems associated with the parameter estimation. This model is also less 
parsimonious than the Lee-Carter model, with an extra parameter included in the 
calculation. Parametric convergence in the iterative scheme for maximum likelihood 
estimations has been found to be very slow suggesting inherent computational flaws 
in the model (Cairns et al. 2009). 




𝛾𝑡−𝑥 +  𝜀𝑥,𝑡 in the 
Renshaw and Haberman leads to the same values of 𝑙𝑛 (𝑚𝑥,𝑡) as LC model. Although 
Cairns et al. (2009) imposed several constraints to fix the identifiability problem, their 
results still suggest that “parameter values in the iterative scheme converge very slowly 
to their maximum likelihood estimates”. 
The model suffers from a trivial correlation structure, as it gives perfect 
correlation between all ages (Cairns et al. 2009). 
In addition to iterative complexity, the model may overestimate the cohort 
effect and run the risk of higher levels of uncertainty in forecasting (Gustafsson 2011). 
In a comparative study of stochastic models in forecasting mortality for male 
populations in England and Wales, Cairns et al. (2011) demonstrated the higher levels 
of uncertainty in the Renshaw-Haberman projections for mortality rates at age 65–75. 
The biological reasonableness or plausibility of the model was also questionable as fan 
chart results and ARIMA models for uncertainty suggested lower uncertainties at age 
85 than at 65. Apart from being counter-intuitive, these observations contradict the 
results obtained from the other models tested and historical evidence of higher 
volatility in death rates at higher ages (Cairns et al. 2011). Comparable results were 
obtained when the Renshaw-Haberman model was fitted to mortality data from the 
US, indicating consistent flaws in this model.  
2.4.2.3  The Age-Period-Cohort model (APC or M3) 
The Age-Period-Cohort model originally described by Currie (2006) is a 
simplification of the Renshaw-Haberman model and is represented as: 
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𝑙𝑛 (𝑚𝑥,𝑡) =  𝑎𝑥 + 𝑘𝑡 + 𝛾𝑡−𝑥 + 𝜀𝑥,𝑡 (2.9) 





normalized to unity, but here are set to 1. The model is constrained by summing the 
period effect 𝑘𝑡 and the cohort effect 𝛾𝑡−𝑥 to zero.  
The APC model has been used to study population trends in demography, 
epidemiology and social-sciences and was first used as far back as 1885 by Farr 
(1885). In this model, the effects of age, period (calendar year) and birth cohort (year 
of birth) additively combine to give the logarithmic mortality rate. The model can be 
evaluated using tests for maximum likelihood.  
The model was fitted with the same data, from England and Wales for male 
mortality at ages 60–89 between 1961 and 2004 (Cairns et al. 2011), as for the previous 
models. Values of age, period and cohort parameter effects were determined using a 
Newton-Raphson iterative scheme. ARIMA (0, 2, 1) models were used for time-series 
evaluation of the cohort effect, and model selection was made based on the BIC 
statistic for parsimony and goodness of fit (Cairns et al. 2011).  
In terms of goodness of fit, the APC model ranked lower than the RH model. 
It also suffered from the problem of a trivial correlation structure. However, forecasts 
for the England and Wales data, illustrated by fan chart outputs, showed higher 
uncertainties at higher ages. This is consistent with historical findings, suggesting 
plausibility and biological reasonableness of the model.  Robustness of the forecast 
was tested by incorporating varying cohort effects into the model. The APC model 
showed good robustness with respect to the data studied, as the cohort variations in the 
forecast were relatively moderate. Similar findings were obtained from the US data.  
Based on BIC statistics, the model ranks second for data from the Netherlands 
(Plat 2009) and is an improvement over the Renshaw-Haberman model in terms of 
parsimony and ease of implementation (Cairns et al. 2009). 
Expert opinion and analysis indicate a number of weaknesses in the APC 
model. The first is that there are no unique set of parameters, as they are all dependent 
(age and period) (Wilmoth 1990) since: 
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Cohort + age = period (2.10) 
Second, it is criticised as being too simplistic in its approximation of reality. 
This is evidenced by the assessment that the model assumes an ageindependent period 
effect when in reality, the rate of improvement of mortality rates over different time 
periods does, in fact, vary with age. Moreover, there has been a perceptible shift in the 
increase in the rate of mortality improvement with age. This is likely to impact each 
generation or cohort. Since cohort effects-such as prenatal maternal nutrition-
accumulates over time, the impact is more likely to be manifested in the elderly, and 
therefore affect mortality rates at higher ages (Willets 2004). This impact is not 
necessarily captured by the model.  
Moreover, the inclusion of the cohort effects necessitates prior knowledge. 
(Wilmoth 1990). For instance, back-tracking the cohort effect of years up to 1945 from 
present-day mortality rates for a population past middle-age would verify existence of 
a cohort that impacts health at higher ages in 2016; however, extrapolating cohort 
effects which may or may not impact future years, (such as AIDS, substance abuse or 
terrorism in the 1980–2000 cohort) is more hypothetical and is likely to give volatile 
projections at higher ages (Plat 2009). The need for the cohort effect was also 
questioned by Cairns et al. (2011) who suggested the replacement of a linear cohort 
effect in the APC model, by linear adjustments to age and period effects.  
The most robust feature of the model is its non-trivial correlation structure, 
making it a reasonable model insolvency calculation. It is also well fitted to historical 
data and is applicable to a full age range (Plat 2009). The APC model is preferred when 
a clear cohort effect is present in the data such as lung cancer or influenza, which is of 
value in health care forecasting (Di Cesar and Murphy 2009).  
2.4.2.4  The Cairns-Blake-Dowd models (M5 and M7)  
Unlike the Lee-Carter class of models which use the central mortality rate (𝑚𝑥,𝑡) for 
estimations, the Cairns-Blake-Dowd model or CBD employs the initial mortality rate 
𝑞𝑥,𝑡(Cairns et al. 2008). 
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The M5 model (Cairns et al. 2008) is a stochastic version of the Perks (1932) 
model and a modification of the CBD two-factor model (Cairns et al. 2006a) and is 
defined as: 
 




 (𝑥 − ?̅? ) + 𝜀𝑥,𝑡  (2.11) 
 








 denote a bivariate random walk 
with drift (Plat 2009) that is: 
 
𝑘𝑡 =  𝑘𝑡−1 +  𝜇 + 𝐶𝑍𝑡 (2.13) 
where 𝜇 and C are constants and Z is a two-dimensional standard normal variable, all 
independent of each other (Cairns et al., 2008). 





 are easy to interpret and may be considered as candidates for mortality 
indices (Chan, Li and Li, 2014).  
The model is unconstrained and does not take into account the cohort effect. 
When compared with other models for England and Wales male mortality data 
between 1981 and 2004, the M5 model showed the highest percent error on 
standardised residuals and ranked most poorly for goodness of fit (Dowd et al. 2010a).  
The model is relatively parsimonious and focuses more on advanced ages of 
60–89 (Cairns et al. 2008). Based on fan charts, the model shows the highest degree 
of volatility at higher ages (>85), which is consistent with historical data. The model 
satisfies the criteria of plausibility (Cairns et al. 2011).   
In terms of robustness, Chan et al. (2014) have reported the M5 model to 
possess the property of new-data-invariance. This means that the addition of a new 
year’s data to existing mortality figures does not affect mortality indices. This is a 
significant advantage since it makes it possible to track historical values. Hence the 
CBD model M5 is most suited to index development.     
The M7 model of Cairns et al. (2008) is a generalisation of the M5 model 
with the addition of the cohort effect and a quadratic term for age: 
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𝑙𝑜𝑔𝑖𝑡 (𝑞𝑥,𝑡) =  𝑘𝑡
(1)
+ 𝑘𝑡
(2)(𝑥 − 𝑥̅ )  +  𝑘𝑡
(3)((𝑥 − 𝑥̅ )2 −  ?̂?𝑥
2) + 𝛾𝑡−𝑥 
(4)
+ 𝜀𝑥,𝑡  (2.14) 
where ?̂?𝑥
2 is the mean of (𝑥 − ?̅? )2. The additional age-period effect 𝑘𝑡
(3)(𝑥 − ?̅? )2 is the 
quadratic age term.  
As with other models that include the cohort effect, M7 also suffers from the 
parameter identification problem. Hence three constraints are applied by summing the 
three period effects (𝑘𝑡) and the cohort effect (𝛾𝑡−𝑥 ) to zero. The quadratic function 
appears to smoothen out unevenness due to cohort effects (Cairns et al. 2009).  
Using BIC ranking, the M7 model ranks the highest of all the models studied 
for robustness for English and Welsh data from 1961–2004 or from 1981–2004. 
Updating the existing dataset by adding or removing data does not change parameter 
estimates (Cairns et al. 2009). The model ranks second (after M8) for goodness of fit 
and parsimony. Standardized residuals satisfy the assumptions of randomness.  
Using the M7 model on US and English and Welsh data the following insights 
were gleaned. 
Wong-Fupuy and Haberman (2004) showed that changes to the period effects 
𝑘𝑡 over time are approximately linear as revealed from M7 forecasts on England -
Wales as well as US data. The model gave plausible forecasts showing the continuing 
decline of mortality rates over time; the rate of decline reduces in advanced years. The 
logit mortality rates and quadratic functions help estimate uncertainties at higher ages 
(>89). Cohort effects are clearly revealed, and were seen to be more prominent in 
England and Wales than in the US.  
The M5 and M7 model have a non-trivial correlation structure, but are limited 
to higher age cohorts. For the full range of ages, the predictions are biologically 
unreasonable, and the models fit poorly for full age ranges (Plat 2009).  
2.4.2.5  Plat model (M8) 
Since each of the models belonging to either the Lee-Carter class or the CBD-Perks 
class of models have their merits and demerits, Plat (2009) formulated a model to 
eliminate the defects with the hope of arriving at the most robust, plausible model best 
fitted to all age ranges. The model attempts to use the salient features of both classes 
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of models. It uses the central mortality rate as in the case of the Lee-Carter class of 
models, but incorporates the parameters incorporated in CBD-Perks class of models.  
The definition of the model is: 
 
𝑙𝑛(𝑚𝑥,𝑡) =  𝑎𝑥+ 𝑘𝑡
(1)
+ 𝑘𝑡
(2)(𝑥 − ?̅? ) + 𝑘𝑡
(3)(𝑥 − ?̅? )++𝛾𝑡−𝑥 
(4)
+ 𝜀𝑥,𝑡  (2.20) 
where the 𝑎𝑥 is the shape of the mortality curve across ages, calculated as a function of average 
central mortality rates over time, as in the Lee-Carter model. ( )+the positive part of the expression. 
𝛾𝑡−𝑥 
(4)






are the three period effects, 
as in the M7 model. The first period effect  𝑘𝑡
(1)
 captures long-term effects of all ages, 
the second  𝑘𝑡
(3)
 is more age specific and the third  𝑘𝑡
(2)
 relates to ages <50. The model 
is constrained by the age effect (𝑎𝑥) summed to one and the four stochastic parameters 
(period effects and cohort effect) summed to zero. Owing to these constraints issues 
relating to parameter identifiability are resolved.   




 makes the model favourable as a non-trivial 
correlation structure.  
This model is flexible accommodating all ages. It can be adjusted for specific 
age groups; for instance, by removing the component 𝑘𝑡
(3)(𝑥 − ?̅? )+  it can be better 
fitted for higher ages (Plat 2009). 
On a BIC ranking for mortality data for males aged 20–90 over four decades 
(1961–2004) the model ranked the highest for US and Netherlands data, and ranked 
second after the RH model for English and Welsh data (Plat 2009).  
Analysis by Cairns et al. (2009) showed that with certain datasets, the M8 
model gave implausible results for the US data as it showed increased mortality rates 
rather than decreasing trends. Cairns et al. (2011) suggested that this may be due to the 
inadequacy of the model to fit age-period effects and that it suffers from overfitting 
the cohort effect. The biological reasonableness of the model diminishes at higher ages 
(Cairns et al. 2011).  
The Plat model has been criticised as being over-parameterized and is not as 
parsimonious as some of the earlier models. However, since it seems to have removed 
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some of the disadvantages of the earlier models and is robust across all ages, this has 
been suggested as the ideal candidate for pricing of longevity associated annuities. 
2.5 Conclusion 
Mortality trends are of infinite importance in a large array of social, economic and 
financial forecasting. This includes economic planning for social security and health, 
retirement income funds, hedge funds as well as actuarial systems in pricing and 
reserving of annuities (Renshaw and Haberman 2006).  
The objective of all the complex iterations using the various models stated 
above is financial forecasting. This includes the calculation of annuity or pensions and 
to adjust longevity risks to pensions and similar annuities. Mortality trends need to be 
extrapolated to the valuation of pension and insurance funds as well as assets and 
liabilities for solvency risk assessments. This will be mandatory under the new 
Solvency Capital Requirement or S2 as elaborated by Plat (2011).   
Mortality rates derived from the best-fitted models are used to estimate the 
age-specific survivor index. For example, the survivor index 𝑆(𝑡,65)  denotes the 
proportion of individuals aged 65 at the start of the calendar year t0 who will remain 
alive at the start of year t0 +t.  
Assuming a constant interest rate, the value of an annuity 𝑃 payable annually 
for the next 25 years to an individual aged 65 at the start of year t0 is calculated by the 
formula: 
 




where v is the discount factor.  
Cairns et al. (2011) concluded in their comparative study on six stochastic 
models for forecasting mortality from male population in England and Wales, that the 
differences in annuity payable are moderate despite variations in mortality rates using 
different forecasting models.   
Wang et al. (2010) studied mortality data from the US using both the Lee-
Carter and CBD model to extrapolate changes in annuity pricing with changes in 
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mortality rate. Their results and extrapolations showed that changed to annuity prices 
following sudden changes in mortality rates can be significantly large. Hence 
forecasters and actuaries need to have contingency measures to hedge longevity risks.   
Quantitative evaluation of different models evaluated by the Bayes 
information criterion (BIC) for data on mortality rates of males aged 20–89 during the 
period 1961–2005 in England and Wales gave the ranking of different models for the 
goodness of fit and parsimony. The Renshaw-Haberman model ranked the highest for 
this dataset, whereas the Plat modification was best suited to data for US males aged 
20–84 during the same period and for Netherlands data from 1951 for males aged 20–
90 (Plat 2009). The Turkish data for males aged 0–90 for the period 1980 to 2012, was 
best fitted by the Renshaw-Haberman model (Kul and Sucu 2015).  
In a separate Italian study, the Renshaw-Haberman model ranked highly for 
ages below 40, while the CBD model was best fitted for the higher age groups of 60–
89 for the period 1952–2003 (Biffi and Clemente 2014).  
Cohort effects were evident for data from England and Wales as well as the US 
data, but are less pronounced after the age of 60 for the US data (Cairns et al. 2009).   
RH, CBD and Plat work well for short time-spans. The LC model is good for 
long-term forecasting, while CBD has the worst BIC ranking for long-term 
forecasting. Projections with ARIMA processes to forecast time-series parameters by 
calendar years were compared for different models to obtain forecasted annuity values. 
The Plat model gave the best fit for short-term data (2004– 2008) for ages 60–70 but 
tends to overestimate survival probabilities in data for higher ages, resulting in lower 
forecast values for annuities. This is also true of the CBD whereas annuities projected 
by the RH model was higher for the Italian data (Biffi and Clemente 2014). 
Biological reasonableness or plausibility is another crucial factor to be 
considered while selecting the best model for forecasting mortality rates. The RH 
model ranked the highest for the England and Wales data in terms of goodness of fit 
and parsimony, but gave unrealistic forecasts.  This may not be true for other datasets.  
The robustness of the model to variation in data is yet another feature to be 
considered. The ease of implementation, and fitting into available computational 
programmes is of practical significance. The RH programme lacked the ease of 
 30 
implementation but was improved by the APC model. These comparisons are seen in 
Table 2.1 and Table 2.2 below. 
Table 2.1 BIC ranking of six stochastic mortality models fitted for data from different 
countries (from Plat, 2009; and Kul and Sucu, 2015) 
Model Model U. S 
England& 
Wales Netherlands Turkey 
LC (1992) M1 4 4 4 6 
RH(2006) M2 2 1 3 1 
Currie (2006) M3 3 3 2 4 
Cairns et al. (2006b)  M5 6 6 6 3 
Cairns et al. (2009) M7 5 5 5 5 
Plat (2009) M9 1 2 1 2 
 
Table 2.2 A comparison of six stochastic mortality models based on criteria satisfaction 
(from Plat, 2009) 
 Criterion 
Model 
LC RH APC M5 M7 M8 
Positive mortality rates + + + + + + 
Consistency historical data +/– + + + + + 
 Long-term biological reasonableness  + + + + + + 
 Robustness + – + + + + 
Forecasts biological reasonable +/– + + + + + 
 Ease of implementation + + + + + + 
Parsimony  + +/– +/– + +/– +/– 
 Possibility generating sample paths + + + + + + 
Allowance for parameter uncertainty + + + + + + 
 Incorporation cohort effects – + + – + + 
Non-trivial correlation structure  – +/– +/– + + + 
Applicable for full age range  +/– +/– +/– – – + 
* +: criterion completely satisfied; +/–: criterion partly satisfied; –: criterion not satisfied. 
The main strengths of the mortality forecasting methods used in this thesis 
are their robustness and the fact that they avoid error in calculation compared to 
traditional methods of mortality and life-expectancy rates calculations. The use of the 
Lee-Carter model and its extensions allow for the errors in mortality rates and life-
expectancy to be examined. Thus, it is possible to assess the degree of confidence 
associated with the conclusions formulated based on of mortality and life-expectancy 
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estimates. Furthermore, using appropriate model selection criteria such as RMSE, AIC 
or BIC, it makes it possible to evaluate the reliability of the estimated rates. 
As seen in these studies, there is no single model that best suits all age groups 
or demographics. No single model is consistently better than the others under all 
conditions. Each model has its merits and demerits; selection of the optimum model 
would depend on the aim of the forecast.  
From comparative studies on six different models, the Plat model seems to be 
best suited for data from a few different countries (Table 2.1) and satisfied almost all 
the required qualitative criteria. However, it too has its flaws under some conditions. 
Hence, it would be prudent to use at least two different models in order to reduce 
uncertainties and avoid unrealistic forecasts. With the variety of models to choose from 
and continuously changing mortality rates alongside the emergence of hitherto 
unforeseen cohorts, it would be best to assess existing and emerging mortality models 
for each dataset and select the one that best suits the dataset in quantitative and 
qualitative terms to produce accurate and realistic forecasts to plan future annuities.  
The purpose of this research is to find models that explain trends in different 
age cohorts of male and female population mortality rates in Australia. 
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Chapter 3 Analysis of Australian Female Mortality 
3.1 Introduction   
The development of mortality rate analysis has progressed with the availability of 
much more data and with the advancement of computational tools (Hill, Thomas, Abou 
Zahr, Walker, Say, Inoue, Suzuki and Maternal Mortality Working Group 2007). The 
modelling and forecasting of long-term trends in mortality is essential for the correct 
pricing of life insurance policies and in the projection of population levels. The 
accurate projection of life-expectancies is important at the national level as it directly 
impacts social security costs (Richards and Currie 2009). 
Section 2.4.1 described that the size of the gap between the male and female 
mortality rates in Australia has varied and increased over the last 150 years. In 
addition, mortality and life-expectancy for both sexes has dramatically improved. This 
chapter is dedicated comprehensively to examine the mortality of just the Australian 
female. Figure 3.1 shows an increase in worldwide average longevity of worldwide 
for females from 54 years in 1960 to 73.6 years in 2014. In Australia, female lifespan 
has increased, on average, from 74 years in 1960 to 84.3 in 2012 and remained 
unchanged in 2013 and 2014. 
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Figure 3.1 Female life-expectancy for Australia and the World - 1960 –2014. 
Data source: World Development Indicators 2016. 
In section 2.4.2, we discussed six stochastic mortality models which are 
currently amongst the most popular models of mortality forecasting. These models are 
the Lee-Carter Model (LC or M1), Renshaw-Haberman model (RH or M2), the Age-
Period-Cohort model (APC or M3), the Cairns-Blake-Dowd model (CBD or M5), M7 
and the Plat model or M8.  All of these models will be examined for modelling of 
Australian Female data.  The choice to use Australian demographic data is based on its 
availability, local context and on the scarcity of actuarial research on this demographic.  
3.2 Objectives 
The main objectives of this chapter are to compare the fit of the six stochastic mortality 
models discussed in section 2.4.2 and to identify the model that is best suited to model 
Australian female mortality rates and life-expectancy. The comparison is based on 
selection criteria encompassing, goodness-of-fit and parsimony of the model. 
Using historical data from past decades (‘look back’ windows) (Dowd et al. 
2010b), each of these models will be tested for their robustness in making accurate future 
predictions (referred to as ‘look forward’ windows) and age brackets based on a varied 
length of historical data. This will allow us to understand the data requirements for 
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years or 30 years of data (look back window) to make 10 years forward (look forward 
window) prediction? Do we need separate models for different age groups? 
After closely assessing each model for efficiency, the best model will then be 
used for projecting death rates and life-expectancy for the Australian female population.  
3.3 Selection criteria for mortality models 
As mentioned in section 2.2, the following statistical criteria enable the evaluation of 
the goodness-of-fit, flexibility and parsimony of the model with respect to the dataset 
in question (Perna and Sibillo 2012: pp. 231–234): 
 C1: the Akaike information criterion (AIC) 
 C2: the Bayesian information criterion (BIC)  
 C3: Colour maps of residual plots, and 
 C4: Root-mean-square-error (RMSE). 
It is important to note that, while predicting mortality trends and life-
expectancies, these predictions are only approximations of reality. Heat-maps of the 
residual plots are a diagnostic and it allows evaluation of models. However, the residual 
plots are subjective and based on judgement, unlike the other three criteria. The 
robustness of these approximations will depend on the property of the model to retain 
and process all the information contained in the dataset, with minimum loss of 
information (Burnham and Anderson 2004). This loss of information is assessed by the 
AIC (Fabozzi, Focardi, Rachev and Arshanapalli 2014: p.399) and BIC statistics (Ando 
2008). The root mean square error is an absolute measure of the difference between 
values predicted by the model and observed values. Hence, the RMSE determines 
prediction errors and is a recommended determinant of the goodness-of-fit of the model 
(Hyndman and Koehler 2006). 
The model with the lowest AIC, BIC and RMSE would be the most suitable. 
Validity of the model is tested by the randomness of residual plots as described by 
Cairns et al. (2009). 
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3.4 Data synthesis and analysis  
Data was sourced from the Human Mortality Database (2016). This dataset consists of 
male and female yearly mortality rates in Australia for the period 1921 to 2010. The 
data included the number of deaths, births, exposures as well as mortality rates and 
life-expectancy at birth. Data for age groups beyond 100 years were not considered.  
The death rate for the age group x in the year t was modelled as a Poisson 
distribution.  
 
d(t, x) = E(t,x) * m(t, x) (3.1) 
where the number of deaths [d(t, x)] is the product of the exposure [E(t,x)] defined as the 
average population during the calendar year t at age x at the last birthday,  and the mortality 
rate for the specific age cohort for a specific year [m(t, x)] (Plat 2009).  
Mortality models were fitted and evaluated using the StMoMo package in R, 
which is available at (http://CRAN.R–project.org/package=StMoMo). Version 0.3.0 
has been used for this study (Villegas, Kaishev and Millossovich 2015).  
3.5 Methodology 
The fitting and robustness of mortality models are investigated for two main 
components. The first part was to determine an appropriate number of years of data 
required for modelling look back window. The second was to identify if modelling for 
different strata of age-groups adds any accuracy to the prediction of mortality rates.  
3.5.1 Study 1: Sensitivity of the look back modelling period 
The sensitivity of past time periods used in modelling would provide insight into the 
number of years of past data that is required to make accurate predictions. This period 
is called the ‘look back window’ (l). The ‘look back window’ defines the number of 
years of past data used for forecast. For instance, a ‘look back window’ of 20 years 
would project mortality outcomes set for a specific year, based on data from the past 
twenty years. The length of the projection would constitute the ‘look forward window’ 
(h). For example, 5–years look forward window (h=5)  and 20–years look back 
window (l), for forecasting of mortality for years 2011(t) will be based on the data for 
years  1986–2006  [t–h– l, t–h]. 
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For a 2–year forecast (h=2) for the year 2011, the modelling period would be 
1989–2009 for l=20. Similarly, for a 3–year forecast (h=3) for 2011 the mode time would 
be   1988–2008 for look back window of 20 years.  For a look back window 20–year for 
the year 2011, with a projection of h=20 years, the data modelled would extend from 
1971– 1991.   The look back window of 20, 30, 40 and 50 years will be referred as ‘Data 
20’, ‘Data 30’, ‘Data 40’ and ‘Data 50’ respectively.  
For different values of l (l=20,30,40, 50) and h (h=1,5, 10, 15, 20 ), stochastic 
models (LC, RH, APC, CBD, M7 and Plat) that are being fitted encompassing data for 
years [t–h– l, t–h] and making h years forward predictions.  The t varies from years 2011 
to 2007.  All these scenarios tested are summarised in Table 3.1 for l =20. 
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Table 3.1 Lists the scenarios that will be tested six stochastic mortality models for look 
back window 20–years. 
Model time [t–h– l, t–h] Year of prediction (t) 































Similar scenarios of data are constructed for l =30 year, 40–year and 50–year 
data and tested for h (h=1, 5, 10, 15, 20) and t=2007, 2008…2011. 
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3.5.2 Study 2: Sensitivity of ages in modelling 
As the mortality changes with age, the second component of the study was to 
determine the impact of age stratification in achieving prediction accuracy. The 
following scenarios for age stratification are considered. All ages are described in 
years. 
 Scenario 0: [0–100]   {S0} 
 Scenario 1: [0–40] [40–60] [60–100] {S1A, S1B, S1C} 
 Scenario 2: [0–60] [60–80] [80–100] {S2A, S2B, S2C} 
The best model was identified based on lowest values of the AIC and BIC 
criteria and RMSE, as well as randomly distributed residuals, derived using R. The R 
Code excerpt and the R-Code steps for fitting of mortality models for the Australian 
data are described in the flowcharts and Appendix A.1 and A.2. 
The workflow followed in this study is presented in Figure 3.2 below. 
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Data a mining 
(Human mortality data base)
Extract Exposure to 



























Forecast Mortality rates 
Forecast Life expectancy
Year of prediction t
t=2011,2010,2009,2008,2007
 
Figure 3.2 The methodology for the present study for construction of mortality models 
for Australian data. 
Table 3.2 below illustrates an example of primary results of the four statistical 
criteria using LC model with data 20 when h=1 for all model time [t–h– l, t–h].  
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Table 3.2 The results of the goodness of fit criteria of data 20 and h=1 using LC model, Australian female. 
 Age Full Age Stratified 
  Scenario 1 Scenario 2 
LC S0 S1A S1B S1C S2A S2B S2C 













































































































































 Age Full Age Stratified 
  Scenario 1 Scenario 2 


































































l: look back window 20–years 
t: year of prediction 
[t–h– l, t–h]: modelling time 
Scenario 0 (S0): [0–100] 
Scenario 1 (S1): S1A=[0–40], S1B=[40–60], S1C=[60–100] 
Scenario 2 (S2): S2A=[0–60], S2B=[60–80], S2C=[80–100] 
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For each of the scenarios (S0, S1 and S2), look forward window (h=1, 5, 10, 
15, 20) prediction for year t (t=2007, 2008, 2009, 2010, 2011), each of the six models 
(LC, RH, APC, CBD, M7, and PLAT) are fitted.  The goodness-of-fit for each case is 
evaluated using the criteria C1 to C4 as above. The RMSES0 is calculated for S0 model 
for S1 and S2 stratification ages.  Selection of these results are presented in Appendix 
B, Table B.1–Table B.5. 
The fitting of Australian mortality data for some scenarios using R, package 
StMoMo was challenging.  There was converge issues, largely due to the default choice 
of ARIMA (0, 0, 1). In some cases, choice of ARIMA (1, 1, 0) model or other form 
resolved the issues.  In other cases, especially with M7 and RH models, reasonable fits 
could not be obtained.  These cases are then not included in subsequent comparisons. 
3.6 Results  
The following sections will present the comparisons of the average RMSE values for the 
six models for different look back windows, look forward windows and different age 
stratification. Each section corresponds to each age stratification, namely S0, S1 and S2. 
3.6.1 Comparison of average RMSE for different look back and look 
forward windows for Scenario S0 
The following sections will present the comparisons of the average RMSE values for the 
six models for different look back windows, look forward windows for Scenario S0. 
First, we consider Data20, which is 20 years look back window. The average 
root mean square error (RMSE) is computed for each of the six models (Lee-Carter, 
RH, APC, CBD, M7 and Plat) and five look forward windows (h=1, h=5, h=10, h=15 
and h=20).  The results are presented in Table 3.3 
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Table 3.3 Average RMSE, Look back Window =20 years, Ages: 0–100, Australian female. 
 
Look Forward Window 
Model h=1 h=5 h=10 h=15 h=20 
LC      0.004126      0.005014     0.007865     0.012181     0.016696 
RH      0.021682      0.056287     0.049121     0.047695     0.08731 
APC      0.004288      0.056287     0.049121     0.047695     0.08731 
CBD      0.016772      0.015972     0.016417     0.013202     0.021916 
M7      0.009326      0.027856     0.048935     0.06883     0.080737 
Plat      0.004191      0.006529     0.011968     0.018304     0.021822 
P-value      0.0000      0.0002     0.0000     0.0000     0.0000 
Each cell in the table presents average RMSE for prediction years 2007–2011.  
P-values reported in the last row are from one-way ANOVA model followed Tukey’s HSD pairwise 
comparisons where appropriate. Groups with lowest and similar average RMSE are presented in bold. 
Red highlight is the case with smallest RMSE. 
As evident from the Table 3.3, the average root mean square error increases 
with an increase in the value of h. The smallest average error for all models is observed 
for the 1–year look forward window, while the highest average RMSE is observed by 
the 20–year look forward window. As expected we are making more error for higher 
look forward window. 
A single factor analysis of variance (ANOVA) comparing average RMSE 
across models for h=1, indicate that average RMSE for all models is not the same. 
Similar results are observed for each value of h. 
For each look forward window LC model results in lowest RMSE values. 
Next comparable model is Plat Model for all look forward windows. The average 
RMSE for other models was at least 2 folds higher. 
For h=1, performance of LC, M7, APC and Plat are comparable, while for 
h=5, performance of LC, M7, Plat and CBD are comparable. Meanwhile, for h=10 and 
h=20, performance of LC, Plat and CBD are comparable, whilst for h=15, performance 
of LC and CBD are comparable. These results are illustrated in Table 3.3 
Secondly Data30, which is 30 years look back window was investigated. The 
Table 3.4 below presents the results of average RMSE of the six stochastic models and 
five distinct look forward windows fitted under non-stratified data, ages 0–100. 
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Table 3.4 Average RMSE, Look back Window =30 years, Ages: 0–100, Australian female 
 
Look Forward Window 
Model h=1 h=5 h=10 h=15 h=20 
LC       0.004078     0.005239     0.007918      0.01096      0.011148 
RH       0.013844     0.057087     0.079713      0.075225      0.057769 
APC       0.005973     0.012563     0.019403      0.022913      0.02388 
CBD       0.016655      0.01675     0.015798      0.01179      0.009459 
M7       0.012727     0.035073     0.058505      0.074904      0.084198 
Plat       0.004751     0.009417     0.016088      0.017513      0.016618 
P-value       0.0001     0.0000     0.0000       0.0000      0.0000 
Each cell in the table presents average RMSE for prediction years 2007–2011.  
P-values reported in the last row are from one-way ANOVA model followed Tukey’s HSD pairwise 
comparisons where appropriate. Groups with lowest and similar average RMSE are presented in bold. 
Red highlight is the case with smallest RMSE. 
As evident from the Table 3.4, the RMSE increases with an increase in the 
value of ‘h’. The smallest average error for all models is given by the 1–year look 
forward window, while the highest average RMSE is given by the 20–year look 
forward window. 
A one-way ANOVA for RMSE comparing average RMSE across models for 
each look forward window, indicate that average RMSE for models is not the same for 
each look forward window. 
As seen in Table 3.4, the groups with lowest and similar average RMSE are 
presented in bold. For all look forward windows LC model results in lowest RMSE 
values.  The next comparable models is Plat Model for look forward windows h= 1, 5, 
15 and 20.  
For h=1 and h=5, the performance of LC, Plat and APC are comparable, 
meanwhile, for h=15 and h=20, the performance of LC, Plat and CBD are comparable. 
While h=10, only LC model is the best performing model.  
Thirdly, we examine Data 40 and the average root mean square error (RMSE) 
is computed for each of the six stochastic models and five look forward windows (h=1, 
h=5, h=10, h=15 and h=20) under the non–stratified data ages: 0–100.  The results are 
presented in Table 3.5 
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Table 3.5 Average RMSE, Look back window=40 years, ages: 0–100, Australian female. 
 
Look Forward Window 
Model h=1 h=5 h=10 h=15 h=20 
LC     0.004143   0.005039 0.006844 0.010417 0.012902 
RH     0.011745   0.030677 0.011771 0.040301 0.047769 
APC     0.008209   0.014756 0.019718 0.023762 0.025839 
CBD     0.016699   0.016253 0.006844 0.010195 0.010045 
M7     0.016722   0.042032 0.065176 0.079735 0.086733 
Plat     0.00572   0.010451 0.014815 0.01625 0.015783 
P-value     0.0000   0.0000 0.0000 0.0000 0.0000 
Each cell in the table presents average RMSE for prediction years 2007–2011.  
P-values reported in the last row are from one-way ANOVA model followed Tukey’s HSD pairwise 
comparisons where appropriate. Groups with lowest and similar average RMSE are presented in bold. 
Red highlight is the case with smallest RMSE. 
Table 3.5 above shows increasing error and decreasing goodness-of-fit with 
increasing values of ‘h’. The minimum RMSE is 0.0041 given by the 1–year look 
forward window using LC model and the maximum RMSE is 0.0867 given by the 20–
year look forward window using M7 model. As expected, the error is larger for higher 
look forward window. 
A one-way ANOVA for RMSE comparing average RMSE across models for 
each look forward window, indicate that average RMSE for models is not the same for 
each look forward window  
As seen in Table 3.5, the groups with lowest and similar average RMSE are 
presented in bold. For each look forward window LC model results in lowest RMSE 
values. The next comparable models are Plat Model (h= 1, 5, 15 and 20) and CBD ( 
h= 10,15and 20). 
For h=1 and h=5, performance of LC and Plat are comparable, while for h=10, 
performance of LC and CBD are comparable. Meanwhile, for h=15, performance of 
LC, Plat and CBD are comparable, whilst for h=20, performance of LC, Plat, APC and 
CBD are comparable. 
Finally, Table 3.6 below show the comparative RMSE for different look 
forward windows for the six mortality model, fitted using non-stratified data for the 
ages 0–100 years using look back window 50-years. 
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Table 3.6 Average RMSE, Look back window=50 years, ages: 0–100, Australian female. 
 
Look Forward Window 
Model h=1 h=5 h=10 h=15 h=20 
LC     0.00415 0.005198 0.007609 0.01096 0.013148 
RH     0.005655 0.013601 0.020135 0.075225 2.948101 
APC     0.010102 0.016232 0.021168 0.022913 0.024911 
CBD     0.016508 0.015663 0.014583 0.01179 0.008242 
M7     0.019765 0.048111 0.070402 0.074904 0.088191 
Plat     0.006761 0.01104 0.014778 0.017513 0.011751 
P-value     0.0000 0.0000 0.0000 0.0000 0.0000 
Each cell in the table presents average RMSE for prediction years 2007–2011.  
P-values reported in the last row are from one-way ANOVA model followed Tukey’s HSD pairwise 
comparisons where appropriate. Groups with lowest and similar average RMSE are presented in bold. 
Red highlight is the case with smallest. 
As evident from the Table 3.6, the average RMSE increases with an increase 
in the value of h. The smallest average error for all models is given by the 1-year look 
forward window, while the highest average RMSE is given by the 20-year look 
forward window.  
A single factor analysis of variance (ANOVA) comparing average RMSE 
across models, shows that for each look forward windows, the average RMSE criterion 
varied significantly between all models (p-value<0.05).  
The groups with lowest and similar average RMSE are presented in bold in 
Table .6. For all look forward window LC model results in lowest RMSE values. Plat 
model is the second best model for look forward windows h= 1, 15 and 20. 
For h=5and h=10, only LC is the best performing model, while for h=1, 
performance of LC, Plat and CBD are comparable. Meanwhile, for h=15, performance 
of LC, Plat and CBD are comparable, whilst for h=20, performance of LC, Plat, APC 
and CBD are comparable. 
Now to understand the sensitivity of length of data required for forward 
prediction, the best performing model is selected for each h, and average RMSE is 
compared for each decade of data acquisition. The results are presented in Figure 3.3. 
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Figure 3.3 RMSE for the different look back and look forward windows, ages: 0–100 
years, Australian female. 
For each value of h, one way ANOVA comparing average RMSE across 4 
decades of look back window resulted in P-value  greater than 0.05, indicating equality 
of mean.  There is not much improvement in RMSE as additional 10 years of modelling 
data is used.  Keeping data acquisition simple, 20 years of data can be safely used for 
modelling. 
The final summary of the best performing modelling method and look back 
window is presented in Table 3.7. 
Table 3.7 Summary of the best of look back and look forward windows using mortality 
models, S0. 
Forward prediction Modelling method Look back window 
h=1 LC and Plat 20 years or more 
h=5 LC and Plat 20 years or more 
h=10 LC 20 years or more 
h=15 LC and CBD 20 years or more 
h=20 LC, Plat and CBD 20 years or more 
In the following sections, we only focus on Data20, which is 20 years look 
back window.  
In the next section we present the comparisons of average RMSE values for 















RMSE for the different lookback windows, ages: 0-100 
years, Australian female
Data20 Data30 Data40 Data50
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3.6.2 Comparison of average RMSE for different look forward 
windows for stratified data (Scenario S1) 
In this section, we consider Data 20 only. The average RMSE is computed for each of 
the six models (Lee-Carter, RH, APC, CBD, M7 and Plat) and five look forward 
windows (h=1, h=5, h=10, h=15 and h=20) for ages 0–40 (Scenario S1A). The results 
are summarized in Table 3.8 below. 
Table 3.8 Average RMSE, Look back window=20 years, ages: 0–40, Australian female. 
 
Look Forward Window 
Model h=1 h=5 h=10 h=15 h=20 
LC     0.000047 0.000069 0.000097 0.000137 0.000087 
RH     0.000054 0.000093 0.000076 0.001422 0.000411 
APC     0.000056 0.000076 0.000067 0.000074 0.000104 
CBD     0.000548 0.000548 0.000550 0.000548 0.000548 
M7     0.000816 0.001995 0.022943 0.448562 0.118579 
Plat     0.000053 0.000057 0.000088 0.000103 0.000075 
P-value     0.0000 0.0000 0.0000 0.0000 0.0000 
Mean     0.0001 0.0001 0.0001 0.0001 0.0001 
t-Statistics     1.4914 0.7804 6.5527 –1.7699 0.1836 
P(T<=t)     0.1051 0.2394 0.0014 0.0757 0.4316 
Each cell in the table presents average RMSE for prediction years 2007–2011. 
P-values reported are from one-way ANOVA model followed Tukey’s HSD pairwise comparisons 
where appropriate. Groups with lowest and similar average RMSE are presented in bold. The Means, 
t-Statistics and P (T<=t) in the last three rows are from paired t-test for comparing RMSE from best 
performing model under S1 and S0 for corresponding ages. Red highlight is the case with smallest 
RMSE. 
The model with the best fit for this dataset for short-term forecasting (h =1) was 
the Lee-Carter model with an RMSE of 0.000047. The model best fitted for this cohort 
for long-term forecasting (h=20) was the Plat model with an average RMSE of 
0.000075 (See Table 3.8).  One way ANOVA show that average RMSE is not the same 
across all models for each look forward windows (p-value<0.05). 
A student’s t-test to compare the average RMSE and average RMSES0 values 
shows that comparable results are obtained for age strata S1A if we model age group 
0–100 years or 0–40 for look forward window h=1,5, 15 and 20. On the other hand, 
for look forward windows h= 10 smaller RMSE are obtained if we model age groups 
0–40 years instead of 0–100 years (P<0.01) (See table 3.8). 
 49 
Second, we consider age-group 40–60, using the same look back window20 
years. The average root mean square error (RMSE) is computed for each of the six 
models (Lee-Carter, RH, APC, CBD, M7 and Plat) and five look forward windows 
(h=1, h=5, h=10, h=15 and h=20).  The results are presented in Table 3.9 
Table 3.9 Average RMSE, Look back window=20 years, ages: 40–60, Australian female. 
 
Look Forward Window 
Model h=1 h=5 h=10 h=15 h=20 
LC     0.000172 0.000219 0.000239 0.000331 0.000334 
RH     0.000161 0.000213 0.000847 0.000322 0.000811 
APC     0.000170 0.000176 0.000176 0.000278 0.000322 
CBD     0.000166 0.000208 0.000199 0.000306 0.000323 
M7     0.000175 0.000215 0.000243 0.000387 0.000491 
Plat     0.000173 0.000215 0.000202 0.000244 0.000298 
P-value     0.8665 0.2167 0.0398 0.0001 0.3676 
Mean     0.0003 0.0003 0.0004 0.0003 0.0004 
t-Statistics     4.1376 7.4931 6.4872 0.8362 0.6589 
P(T<=t)     0.0072 0.0008 0.0015 0.2250 0.2730 
Each cell in the table presents average RMSE for prediction years 2007–2011.  
P-alues reported are from one-way ANOVA model followed Tukey’s HSD pairwise comparisons 
where appropriate. Groups with lowest and similar average RMSE are presented in bold. The Means, 
t-Statistics and P (T<=t) in the last three rows are from paired t-test for comparing RMSE from best 
performing model under S1 and S0 for corresponding ages. Red highlight is the case with smallest 
RMSE. 
For both the long-term (h=20) and short-term (h=1,5) forecasting 
performance of all modelling methods are comparable.  For  h=10 and 15, APC, CBD 
and Plat are comparable and best-performing models. 
A student’s t-test to compare the average RMSE and average RMSES0 values 
shows that comparable results are obtained, for age strata S1B if we model age group 
0–100 years or 40–60 for look forward window h=15 and 20. On the other hand, for 
look forward windows h= 1, 5 and 10 smaller RMSE are obtained if we model age 
groups 40–60 years instead of 0–100 years (See Table 3.9). 
Finally, Table 3.10 below shows the comparative RMSE for different look 
forward windows for the six mortality model, fitted using scenario S1 data for the ages 
60–100 years. 
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Table 3.10 Average RMSE, Look back window=20 years, ages: 60–100, Australian female. 
 
Look Forward Window 
Model h=1 h=5 h=10 h=15 h=20 
LC 0.006516 0.008007 0.012551 0.019668 0.026682 
RH 0.036263 0.072645 0.101996 0.128354 0.133283 
APC 0.006679 0.012995 0.021889 0.034421 0.042235 
CBD 0.012667 0.012225 0.014294 0.012965 0.021186 
M7 0.006847 0.016358 0.029952 0.051601 0.063263 
Plat 0.006351 0.005959 0.007153 0.017438 0.024888 
P-value 0.0000 0.0004 0.0000 0.0000 0.0000 
Mean 0.0066 0.0102 0.0188 0.0287 0.0343 
t-Statistics 0.3344 4.5675 21.3177 7.5591 2.9284 
P(T<=t) 0.3774 0.0051 0.0000 0.0008 0.0214 
Each cell in the table presents average RMSE for prediction years 2007–2011.  
P-values reported are from one-way ANOVA model followed Tukey’s HSD pairwise comparisons 
where appropriate. Groups with lowest and similar average RMSE are presented in bold. The Means, 
t-Statistics and P (T<=t) in the last three rows are from paired t-test for comparing RMSE from best 
performing model under S1 and S0 for corresponding ages. Red highlight is the case with smallest 
RMSE. 
A single factor analysis of variance (ANOVA) comparing average RMSE 
across models for h=1, indicate that average RMSE for all models is not the same. 
Similar results are observed for each value of h. (p-value<0.05). 
A student’s t-test to compare the average RMSE and average RMSES0 values 
shows that comparable results are obtained, for age strata S1C if we model age group 
0–100 years or 60–100 for look forward window h=1. On the other hand, for look 
forward windows of 5  or more year, smaller RMSE are obtained if we model age 
groups 60–100 years instead of 0–100 years (P<0.01) (See Table 3.10).  
Overall, for stratified scenario S1 for group 60–100 years, the Lee-Carter and 
Plat models had the lowest average RMSE for all values of different look forward 
windows ‘h’. As seen in Table 3.10, the groups with lowest and similar average RMSE 
are presented in bold.  
The following is a comparison of the average RMSE values for the six models 
for all age cohort groups of the third scenario for different look forward windows. 
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3.6.3 Comparison of average RMSE for different look forward 
windows for stratified data (Scenario S2) 
Further stratification of data in scenario (S2) for stratified age data (Scenario S2: A=0–
60, B=60–80, C=80–100) as seen below in Tables 3.11–3.13 that compare the 
goodness-of-fit in terms of RMSE between different look forward windows for the six 
different models using Data for 20–years. 
Table 3.11 Average RMSE, Look back window=20 years, ages: 0–60, Australian female. 
 
Look Forward Window 
Model h=1 h=5 h=10 h=15 h=20 
LC     0.000110 0.000140 0.000161 0.000226 0.000227 
RH     0.000170 0.001478 0.000125 0.000187 0.000774 
APC     0.000107 0.000117 0.000113 0.000152 0.000194 
CBD     0.000538 0.000559 0.000574 0.000605 0.000602 
M7     0.000656 0.000912 0.001224 0.001848 0.007118 
Plat     0.000105 0.000103 0.000124 0.000139 0.000173 
P-value     0.0000 0.0000 0.0000 0.0000 0.0000 
Mean     0.0001 0.0001 0.0001 0.0001 0.0001 
t-Statistics     –0.5487 1.4692 –2.9186 0.6301 –2.2056 
P(T<=t)     0.3062 0.1079 0.0217 0.2814 0.0460 
Table 3.12 Average RMSE, Look back window=20 years, ages: 60–80, Australian female. 
 
Look Forward Window 
Model h=1 h=5 h=10 h=15 h=20 
LC      0.000599 0.000680 0.001098 0.001578 0.001381 
RH      0.002200 0.012529 0.001585 0.012797 0.015169 
APC      0.000624 0.000744 0.000746 0.000891 0.001473 
CBD      0.000910 0.000884 0.001012 0.001481 0.001454 
M7      0.000575 0.000802 0.000951 0.001550 0.002032 
Plat      0.000581 0.000673 0.000949 0.001540 0.001801 
P-value      0.0336 0.0000 0.0030 0.0000 0.0000 
Mean      0.0005 0.0005 0.0008 0.0011 0.0016 
t-Statistics      –1.0817 –2.0233 –1.7828 –3.5489 –2.8948 
P(T<=t)      0.1701 0.0565 0.0746 0.0119 0.0222 
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Table 3.13 Average RMSE, Look back window=20 years, ages: 80–100, Australian female. 
 
Look Forward Window 
Model h=1 h=5 h=10 h=15 h=20 
LC       0.008964 0.010661 0.017297 0.028374 0.038343 
RH       0.038253 0.113141 0.195040 0.195454 0.168864 
APC       0.008782 0.015506 0.026796 0.046440 0.051861 
CBD       0.023231 0.021833 0.027173 0.019453 0.030748 
M7       0.009522 0.017743 0.021693 0.024532 0.044230 
Plat       0.008486 0.007197 0.009120 0.021993 0.029137 
P-value       0.0003 0.0000 0.0000 0.0000 0.0000 
Mean       0.0092 0.0143 0.0262 0.0401 0.0478 
t-Statistics       1.4658 4.3374 7.6438 10.6797 2.0363 
P(T<=t)       0.1083 0.0061 0.0008 0.0002 0.0557 
Each cell in the table presents average RMSE for prediction years 2007–2011.  
P-values reported are from one-way ANOVA model followed Tukey’s HSD pairwise comparisons 
where appropriate. Groups with lowest and similar average RMSE are presented in bold. The Means, 
t-Statistics and P (T<=t) in the last three rows are from paired t-test for comparing RMSE from best 
performing model under S1 and S0 for corresponding ages. Red highlight is the case with smallest 
RMSE. 
One way ANOVA for the goodness-of-fit for different values of h revealed 
that there was no significant difference in the goodness-of-fit for all models fitted with 
stratified data for scenario S2 (p-value<0.05) (See Tables 3.10–3.13). 
A student’s t-test to compare the average RMSE and average RMSES0 values 
shows that for h=15, modelling for age groups 60–80 or 80–100 gives better prediction 
(P<0.01) (See Table 3.12–3.13). On the other hand, for age groups 0–60 years models 
fitted for ages 0–100 are comparable to model fitted for stratified ages (P>0.05) (See 
Table 3.11). There is not much again in stratification at other look forward windows. 
In summary, based on the results of the RMSE for look forward windows, for 
stratified scenario S2 for group 80–100 years, it may be inferred that the Lee-Carter 
model and Plat model models had the lowest average RMSE for all values of different 
look forward windows ‘h’. The groups with lowest and similar average RMSE are 
presented in bold (See Table 3.13). 
The next section will compare the goodness-of-fit for each of the six stochastic 
models separately based on all the selection criteria for each of age cohort scenarios. 
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3.6.4 Comparison of average AIC and BIC for different scenarios 
The purpose of this section is to illustrate that the best performing models on RMSE 
are also good performing models on AIC and BIC criterion.  
The comparisons between the average AIC and BIC values for 1-–year look 
forward window using look back window 20-years were illustrated in Figure 3.4– Figure 
3.10 below. The comparison shows that the best fitted models for scenario S0 (0–100 
years, non-stratified data) are (LC, Plat and APC) also have lower AIC and BIC values.  
 
Figure 3.4 A comparative assessment of the six mortality models with respect to S0 for 
ages 0–100, h=15, Data 20, Australian female. 
Figure 3.5 below shows that once again for scenario S1A (0–40 years) the 
best fitted model according to RMSE (APC, Plat, LC and RH) are also the models with 
a lower range of AIC and BIC values.  
For the same scenario, stratified data 40–60 years, the Renshaw-Haberman and 
the APC models give the best results according to the AIC and RMSE criteria, while 
according to the BIC criterion the Lee-Carter models and APC are the best fitted model 
for this dataset (Figure 3.6 below). However, AIC and BIC values for best performing 
models for RMSE (Plat, APC and CBD) are comparable to the best scenario.  
Figure 3.7 below, presents AIC and BIC values for S1C (60–100 years). Once 
again, the best performing models for RMSE (Plat and LC) have lower range of AIC 




















AIC and BIC for six stochastic models for data size 
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Figure 3.5 A comparative assessment of the six mortality models with respect to S1 for 
ages 0–40, h=15, Data 20, Australian female. 
 
Figure 3.6 A comparative assessment of the six mortality models with respect to S1 for 
ages 40–60, h=15, Data 20, Australian female. 
 
Figure 3.7 A comparative assessment of the six mortality models with respect to S1 for 
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 55 
Finally, for scenario S2A (0–60 years), data 20, 15–year look forward 
window, the results show that according to the AIC criterion the best fitted models are 
the Plat and the APC models. The BIC and RMSE criteria give the LC, Plat and RH 
models as the best models to estimate mortality and life-expectancy rates for this 
dataset. On the other hand, the LC and the APC models are the best fitted models for 
scenario S2B (60–80 years) according to the AIC and the BIC criterion, while 
according to RMSE the Plat and APC models are the best. Finally, for scenario S2C 
(80–100 years) the AIC criterion gives  the RH and Plat models as the best fitted 
models, the BIC criterion  gives the Lee-Carter and the APC models, while the 
minimum RMSE values are given by the Plat and the CBD models (Figure 3.8 – Figure 
3.10 below). 
 
Figure 3.8 A comparative assessment of the six mortality models with respect to S2 for 
ages 0–60, h=15, Data 20, Australian female. 
 
Figure 3.9 A comparative assessment of the six mortality models with respect to S2 for 
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Figure 3.10 A comparative assessment of the six mortality models with respect to S2 for 
ages 80–100, h=15, Data 20, Australian female. 
In summary, the best performing models for RMSE (LC and Plat) have lower 
ranges of AIC and BIC values. 
3.6.5 Randomness of residuals 
The fourth criteria to be satisfied were the randomness of residuals. The residuals for 
the models were randomly distributed, as computed using the StMoMo R package. 
(Figure 3.11 and Figure 3.12). 
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The distribution of residuals for the Lee-Carter model is random and indicates 
deterioration in mortality (red cells). The decline in mortality is seen across all ages 
represented in the model.  
 
Figure 3.12 Parameter estimation for Lee-Carter model, Australian female. 
Parameter estimations for the age-coefficients (𝛼𝑥) and (𝛽𝑥) and the period 
effect or mortality index (𝑘𝑡) follow exponential and linear trends respectively, which 
are typical for the Lee-Carter model. No cohort effect is expected or apparent. The 
central mortality rate predicted by the model varies logarithmically with 𝛼𝑥, 𝛽𝑥 and 𝑘𝑡 
as ln 𝑚(𝑥,𝑡) =  𝛼(𝑥) +   𝛽(𝑥)𝑘(𝑡) + 𝜀(𝑥,𝑡)   (Cairns et al. 2011).  
3.6.6 Summary of results 
In summary, the following assumptions can be made. Based on the four 
criteria for model selection, the Lee-Carter model appears to be a good model across 
all scenarios. In addition, the model with the lowest error (RMSE) across all look back 
and look forward windows, age-based stratification and data sizes, also had the lowest 
BIC and a low AIC. Hence, on this basis, the best model for estimating mortality and 
life-expectancy for this dataset would be the Lee-Carter model. The CBD and M7 
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models had the highest values for the RMSE as well as BIC and AIC, suggesting a 
poor selection for this dataset.  
Regarding the size of the data (look back windows), there was no significant 
difference in the goodness-of-fit for the Australian female mortality data, between the 
different data sizes (Data 20 to Data 50) for the six stochastic models studied. 
However, using age stratification data for ages 60 to 100 or 80 to 100 led to improved 
results in the model fit. 
3.7 Calculating mortality 
Mortality 𝑚(𝑥,𝑡) and the number of deaths between the ages x and 𝑥(𝑡+1) were 
determined using the StMoMo package for all the models used. The Lee-Carter model, 
which ranked the highest, based on the selection criteria of goodness-of-fit, BIC, AIC 
and random distribution of residuals, was compared with the CBD model which fitted 
most poorly to the data and ranked the lowest with respect to the selection criteria.  
The mortality rate 𝑚(𝑥,𝑡) and the number of deaths for age x at time t 𝐷(𝑥,𝑡) 
were computed using the StMoMo package for the R statistical programme and 
obtained from the original mortality tables (www.mortality.org).  Central mortality 
rates 𝑚(𝑥,𝑡) are calculated using the equations (2.3) and (2.4) in Chapter 2. 
The life-expectancy for a specific age was calculated based on the method 
described by Arias (2014), Strauss, Shavelle and Brook, www.lifeexpectancy.org 
(2016); Anderson (1999) and Slud (2001). 
The residual life-expectancy, at age x, (𝑒𝑥, or the average survival time at age x) 
is calculated as:  
 
𝑒𝑥 = sum (𝑇𝑥  / 𝑙𝑥  ) (3.2) 
where 𝑙𝑥 is the survivor function for age x, and 𝑇𝑥 is the total number of persons alive after 
the age of x years. 
𝑇𝑥 is obtained from the mortality tables, while  𝑙𝑥 was calculated using the formula: 
 
𝑙𝑥  = 𝑑𝑥 / 𝑚𝑥  (3.3) 
where 𝑑𝑥 is the number of deaths between the ages x and x+1, and 𝑚𝑥 is the mortality rate 
computed by the model. 
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The estimated mortality rates and number of deaths from the Lee-Carter 
model and CBD model are tabulated in Table 3.14. Calculated life-expectancy using 
mortality rates from both models and population data from life-tables 
(www.mortality.org) is presented in Table 3.15. 
The forecasted mortality rates for h1, h5, h10 and h20 for the age group 60–
100 are presented in Tables 3.16 and 3.17 with and Figures 3.13–3.15 below.  
Mortality rates from life-tables (www.mortality.org) for a 65–year–old 
Australian woman in 2011 was 0.00613. The mortality rate for the same cohort derived 
from the Lee-Carter model is 0.00602, and from the CBD model, is 0.00491 (see Table 
3.14).  
Table 3.14 Mortality rate [𝒎(𝒙,𝒕)] and number of deaths [𝑫(𝐱,𝒕)] computed by the CBD 
and Lee-Carter Models and original Australian female data for year=2011, 
ages=60-–100. 
 
Mortality rate [𝒎(𝒙,𝒕)]  Number of deaths [𝑫(𝒙,𝒕)] 
Age  CBD LC original CBD LC original  
60 0.002513 0.003966 0.00416 238.5375 376.4541 394 
61 0.002874 0.00429 0.00466 271.6138 405.511 439 
62 0.003286 0.004729 0.00471 309.1104 444.9459 442 
63 0.003756 0.005124 0.00483 351.742 479.8065 452 
64 0.004294 0.005632 0.00525 400.1742 524.8221 488 
65 0.004909 0.006023 0.00613 455.05 558.354 567 
66 0.005611 0.006988 0.00643 516.9533 643.8092 590 
67 0.006413 0.007735 0.00746 587.039 708.0515 680 
68 0.007328 0.008326 0.00802 665.8698 756.5207 726 
69 0.008374 0.00932 0.00927 754.768 840.1002 832 
70 0.009566 0.010327 0.01034 854.3225 922.2054 919 
71 0.010927 0.011834 0.01188 965.8188 1045.955 1044 
72 0.012479 0.012887 0.01342 1089.969 1125.616 1164 
73 0.014249 0.014 0.01428 1227.918 1206.531 1222 
74 0.016265 0.01592 0.01701 1381.772 1352.522 1433 
75 0.018561 0.017594 0.01727 1550.233 1469.538 1430 
76 0.021174 0.019626 0.01956 1738.201 1611.122 1590 
77 0.024145 0.023115 0.02261 1943.776 1860.854 1800 
78 0.027523 0.025654 0.02546 2166.111 2019.072 1978 
79 0.031357 0.028957 0.02785 2405.85 2221.723 2107 
80 0.035706 0.034109 0.03407 2664.274 2545.139 2500 
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Mortality rate [𝒎(𝒙,𝒕)]  Number of deaths [𝑫(𝒙,𝒕)] 
Age  CBD LC original CBD LC original  
81 0.040633 0.039281 0.03734 2930.36 2832.831 2644 
82 0.046207 0.044496 0.04518 3210.159 3091.287 3069 
83 0.052504 0.050529 0.05251 3486.521 3355.353 3398 
84 0.059605 0.057116 0.05746 3755.523 3598.666 3519 
85 0.067599 0.065475 0.0677 4021.28 3894.917 3895 
86 0.076577 0.07457 0.07965 4257.059 4145.515 4258 
87 0.086637 0.086089 0.09063 4447.443 4419.335 4451 
88 0.097878 0.098516 0.10455 4588.8 4618.707 4658 
89 0.110401 0.110403 0.12488 4661.741 4661.829 4963 
90 0.124306 0.125646 0.14225 4631.955 4681.867 4949 
91 0.139687 0.142639 0.15577 4513.858 4609.222 4670 
92 0.156631 0.160524 0.17263 4329.842 4437.438 4393 
93 0.175212 0.176416 0.194 4073.862 4101.842 4112 
94 0.195486 0.195922 0.2247 3741.416 3749.752 3866 
95 0.217488 0.215715 0.24836 3321.694 3294.62 3374 
96 0.241223 0.237768 0.27733 2870.315 2829.198 2898 
97 0.266666 0.260787 0.30829 2400.261 2347.346 2404 
98 0.293753 0.284737 0.34108 1937.598 1878.127 1922 
99 0.322383 0.309331 0.37547 1506.818 1445.814 1478 
100 0.35241 0.334132 0.41115 1126.655 1068.22 1090 
 
Table 3.15 Calculation of life-expectancy of Australian female from modelled mortality rates 
for year=2011, ages=60-–100. 
 
Number of survivors [𝒍𝒙]  
Life-expectancy [𝒆(𝒙,𝒕)] 
Age  CBD LC (Original) 𝑻𝒙 (original) CBD LC (Original) 
60 95028.46 94890.55 94915 2514660 26.462177 26.500638 26.49381 
61 94643.39 94509.49 94521 2419942 25.569056 25.605281 25.602162 
62 94211.89 94076.05 94082 2325640 24.685207 24.72085 24.719287 
63 93730.26 93602.19 93640 2231780 23.810667 23.843245 23.833618 
64 93239.83 93115.18 93188 2138366 22.934041 22.964742 22.946796 
65 92732.95 92629.65 92700 2045422 22.057122 22.081721 22.064962 
66 92183.05 92056.19 92133 1953006 21.186173 21.215368 21.197682 
67 91545.96 91424.95 91542 1861168 20.330422 20.357332 20.331301 
68 90876.13 90785.48 90862 1769966 19.476688 19.496135 19.479716 
69 90107.23 90021.9 90136 1679467 18.638537 18.656205 18.632589 
70 89281.68 89213.79 89305 1589746 17.80596 17.819509 17.80131 
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Number of survivors [𝒍𝒙]  
Life-expectancy [𝒆(𝒙,𝒕)] 
Age  CBD LC (Original) 𝑻𝒙 (original) CBD LC (Original) 
71 88339.18 88259.04 88386 1500901 16.990207 17.005634 16.981207 
72 87296.03 87260.38 87342 1413036 16.186715 16.193328 16.178196 
73 86114.08 86135.47 86178 1326276 15.401384 15.397559 15.38996 
74 84796.23 84825.48 84956 1240709 14.631653 14.626608 14.604136 
75 83405.77 83486.46 83523 1156470 13.865588 13.852186 13.846126 
76 81784.8 81911.88 82093 1073662 13.127892 13.107525 13.078606 
77 80149.22 80232.15 80503 992364 12.381455 12.368658 12.327044 
78 78336.89 78483.93 78703 912762 11.651752 11.629922 11.59755 
79 76297.15 76481.28 76725 835048 10.944681 10.918332 10.883649 
80 74060.73 74179.86 74617 759377 10.253437 10.23697 10.176997 
81 71686.64 71784.17 72118 686009 9.5695515 9.55655 9.5123132 
82 68907.84 69026.71 69474 615213 8.9280551 8.9126799 8.8552984 
83 65987.48 66118.65 66405 547274 8.2936037 8.2771507 8.2414577 
84 62649.48 62806.33 63007 482568 7.7026661 7.6834288 7.6589585 
85 58985.72 59112.08 59488 421321 7.1427627 7.1274937 7.0824536 
86 55230.94 55342.49 55592 363781 6.5865436 6.5732682 6.5437653 
87 51144.56 51172.67 51334 310318 6.0674688 6.0641359 6.0450773 
88 46745.2 46715.29 46883 261210 5.5879534 5.5915308 5.5715291 
89 42221.26 42221.17 42225 216656 5.1314434 5.1314541 5.1309888 
90 37593.05 37543.13 37262 176912 4.7059768 4.7122333 4.7477859 
91 32748.14 32652.78 32313 142124 4.3399103 4.3525853 4.3983536 
92 27983.16 27875.56 27644 112145 4.0075892 4.023058 4.0567573 
93 23570.14 23542.16 23251 86698 3.6782984 3.68267 3.7287859 
94 19509.58 19501.25 19139 65503 3.357478 3.3589132 3.4224881 
95 15817.31 15844.38 15273 48297 3.0534276 3.0482102 3.1622471 
96 12402.69 12443.8 11899 34712 2.7987488 2.789501 2.9172199 
97 9498.739 9551.654 9001 24262 2.5542338 2.5400837 2.6954783 
98 7063.402 7122.873 6596 16463 2.3307466 2.3112864 2.4959066 
99 5089.182 5150.186 4674 10828 2.1276502 2.1024482 2.3166453 
100 3547.345 3605.78 3197 6893 1.9431436 1.911653 2.1560838 
 
Table 3.16 Mortality forecasts for forward look windows h=1, h=5 and h=10. 
 
2012 2016 2021 
Age LC CBD LC CBD LC CBD 
60 0.003886 0.002442 0.003581 0.002176 0.003232 0.001884 
61 0.004206 0.002794 0.003887 0.002495 0.003522 0.002167 
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2012 2016 2021 
Age LC CBD LC CBD LC CBD 
62 0.00463 0.003196 0.004253 0.002862 0.003824 0.002492 
63 0.005014 0.003656 0.004599 0.003282 0.004128 0.002867 
64 0.005515 0.004182 0.00507 0.003763 0.004563 0.003297 
65 0.005893 0.004784 0.005399 0.004315 0.004839 0.003792 
66 0.006852 0.005471 0.006335 0.004947 0.005743 0.004361 
67 0.007581 0.006257 0.006995 0.005671 0.006326 0.005014 
68 0.008154 0.007155 0.007499 0.0065 0.006753 0.005765 
69 0.009127 0.00818 0.008393 0.00745 0.007558 0.006628 
70 0.010114 0.009351 0.009304 0.008538 0.008382 0.007619 
71 0.011615 0.010688 0.010777 0.009783 0.009813 0.008757 
72 0.012621 0.012214 0.01161 0.011207 0.010457 0.010063 
73 0.013701 0.013954 0.012563 0.012836 0.011271 0.011561 
74 0.015587 0.015939 0.014322 0.014698 0.012882 0.01328 
75 0.017224 0.0182 0.015818 0.016825 0.014219 0.01525 
76 0.019216 0.020775 0.017659 0.019255 0.015886 0.017507 
77 0.022691 0.023706 0.021068 0.022028 0.019198 0.020092 
78 0.02515 0.02704 0.023229 0.025189 0.021028 0.023049 
79 0.028393 0.030827 0.026243 0.028791 0.023776 0.026429 
80 0.03352 0.035125 0.031261 0.03289 0.028643 0.03029 
81 0.038687 0.039998 0.036398 0.037551 0.033719 0.034695 
82 0.043792 0.045515 0.041083 0.042843 0.037921 0.039714 
83 0.04974 0.051752 0.0467 0.048843 0.043148 0.045425 
84 0.056221 0.05879 0.052771 0.055634 0.048739 0.051913 
85 0.064547 0.066719 0.060957 0.063307 0.056732 0.05927 
86 0.073536 0.075632 0.069527 0.071957 0.064801 0.067595 
87 0.085065 0.085625 0.081079 0.081686 0.076336 0.076994 
88 0.097512 0.096801 0.093586 0.092599 0.088879 0.087578 
89 0.109277 0.109261 0.104872 0.104804 0.099586 0.099459 
90 0.124552 0.123107 0.12026 0.118408 0.115075 0.112753 
91 0.141637 0.138434 0.137687 0.133513 0.132882 0.127572 
92 0.159427 0.155331 0.155101 0.150218 0.149829 0.144022 
93 0.175273 0.173875 0.170763 0.168606 0.165254 0.1622 
94 0.194781 0.194124 0.190268 0.188745 0.184739 0.182183 
95 0.214603 0.216114 0.210194 0.21068 0.204776 0.204029 
96 0.236724 0.239853 0.232583 0.234427 0.227478 0.227765 
97 0.259834 0.265318 0.256045 0.25997 0.251359 0.253384 
98 0.283908 0.292446 0.280604 0.287251 0.276508 0.280835 
99 0.30865 0.321136 0.305934 0.316172 0.302559 0.310026 
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2012 2016 2021 
Age LC CBD LC CBD LC CBD 
100 0.333612 0.351242 0.331536 0.346589 0.328951 0.340814 
 
Table 3.17 Mortality forecasts of Australian female for forward look windows h=15, h=20 
and h=50. 
 2026 2031 2061 
Age LC CBD LC CBD LC CBD 
60 0.002918 0.001631 0.002634 0.001412 0.001424 0.000594 
61 0.003191 0.001881 0.002891 0.001633 0.001598 0.000699 
62 0.003438 0.002171 0.003091 0.00189 0.001631 0.000824 
63 0.003705 0.002504 0.003325 0.002187 0.001736 0.000971 
64 0.004107 0.002889 0.003696 0.002531 0.001963 0.001144 
65 0.004337 0.003332 0.003887 0.002928 0.002012 0.001347 
66 0.005206 0.003844 0.004719 0.003388 0.002615 0.001587 
67 0.00572 0.004434 0.005172 0.00392 0.002824 0.00187 
68 0.006082 0.005113 0.005476 0.004534 0.002916 0.002203 
69 0.006805 0.005896 0.006127 0.005245 0.003259 0.002595 
70 0.007551 0.006799 0.006801 0.006066 0.003628 0.003056 
71 0.008935 0.007838 0.008135 0.007015 0.004627 0.003599 
72 0.009418 0.009035 0.008482 0.008111 0.004516 0.004238 
73 0.010111 0.010412 0.009069 0.009376 0.004713 0.00499 
74 0.011585 0.011997 0.010418 0.010837 0.005496 0.005875 
75 0.012779 0.01382 0.011483 0.012522 0.006032 0.006915 
76 0.014289 0.015915 0.01285 0.014466 0.006779 0.008138 
77 0.017491 0.018323 0.015933 0.016707 0.009081 0.009576 
78 0.019031 0.021086 0.017221 0.019287 0.009423 0.011264 
79 0.021537 0.024256 0.019504 0.022258 0.010721 0.013246 
80 0.026238 0.027889 0.024031 0.025674 0.014133 0.015572 
81 0.031231 0.032048 0.028921 0.029598 0.018179 0.018298 
82 0.034993 0.036804 0.032284 0.034101 0.019828 0.021491 
83 0.039855 0.042236 0.036803 0.039261 0.022718 0.025227 
84 0.045001 0.048428 0.041536 0.045166 0.025553 0.029593 
85 0.052784 0.055475 0.049096 0.05191 0.03163 0.034688 
86 0.060375 0.06348 0.056234 0.059599 0.036505 0.040622 
87 0.071849 0.072551 0.067606 0.068345 0.046681 0.047523 
88 0.084387 0.082804 0.080101 0.078268 0.058322 0.055527 
89 0.094539 0.094358 0.089723 0.089492 0.065215 0.064788 
90 0.110085 0.107335 0.105286 0.102148 0.080208 0.07547 
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 2026 2031 2061 
Age LC CBD LC CBD LC CBD 
91 0.128218 0.121858 0.123696 0.116365 0.099356 0.087748 
92 0.144706 0.138041 0.139729 0.132269 0.11281 0.101804 
93 0.15989 0.155992 0.154667 0.149978 0.126208 0.11782 
94 0.179335 0.175801 0.174056 0.169595 0.144933 0.135975 
95 0.199464 0.197536 0.194255 0.1912 0.165167 0.156431 
96 0.222453 0.221238 0.217507 0.214846 0.18951 0.179326 
97 0.246731 0.246909 0.24216 0.240546 0.215961 0.204758 
98 0.272449 0.274508 0.268428 0.26827 0.245101 0.232774 
99 0.299204 0.303947 0.295871 0.297935 0.276333 0.263354 
100 0.326376 0.335085 0.323811 0.329405 0.308648 0.296399 
 
As seen in Table 3.16 - Table 3.17, the mortality rates over different values 
of h (h1–h50) were not significantly different between the Lee-Carter model and CBD 
model as determined by the student’s t-test (P>0.05). 
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Figure 3.14 Mortality forecast of Australian female-CBD model. 
 
Figure 3.15 Comparative mortality forecasts by the Lee-Carter and CBD models using 
Australian female data. 
The graphs from Figure 3.13 to Figure 3.15 presented the mortality rates 
predicted by the Lee-Carter and CBD models, as observed, the mortality rates of 
Australian female population aged 60–100 decline over 50 years in the period from 
1961 to 2011. This age cohort was fitted into the models to predict female mortality 
with a forecasting period of 1 year (2012), 5 years (2016), 10 years (2021) 15 years, 
(2026), 20 years (2031) and fifty years (2061). Based on current population figures, 

















































































































Mortality forecast CBD model
60 61 62 63 64 65 66 67 68 69 70
71 72 73 74 75 76 77 78 79 80 81
82 83 84 85 86 87 88 89 90 91 92










LC CBD LC CBD LC CBD LC CBD LC CBD LC CBD



















Mortality forecast (CBD and Lee-Carter) 
60 61 62 63 64 65 66 67 68 69 70
71 72 73 74 75 76 77 78 79 80 81
82 83 84 85 86 87 88 89 90 91 92
 66 
with an expected life–span of 87.06 years. Using mortality rates predicted by the Lee-
Carter model, the residual life-expectancy for an Australia woman aged 65 in 2011, is 
22.081 while the CBD model gives a residual life-expectancy of 22.057 years, for the 
same individual. 
The CBD model was compared with the Lee-Carter model to determine 
whether the difference in selection criteria would influence the actual mortality rate 
estimation. 
In all cases, the difference between CBD model, LC and the life-expectancy 
from the life-tables at www.mortality.org were not significantly different as 
determined by the t-test (P>0.05) indicating that the statistical goodness-of-fit did not 
significantly impact on the forecasting of life-expectancy, for this dataset, for ages 60–
100 years.  
Hence, the choice of the model for forecasting mortality and life-expectancy 
is perhaps based on qualitative rather than quantitative criteria, as was earlier 
suggested (Biffi and Clemente 2014; Plat 2009). The Lee-Carter model also gave a 
similar estimate of life-expectancy as the CBD model, which has previously been 
recommended for older age groups (Biffi and Clemente 2014). 
3.8 Discussion  
Stochastic modelling of mortality data has been a preferred choice for forecasting 
survival of the human population over the last hundred years (Dellaportas, Smith and 
Stavropoulos 2001). The main advantage of using stochastic models is the facility to 
compare data and predict changes over time and space (Pollard 1989). On this 
principle, the current research has addressed the issue of female mortality and life-
expectancy forecasting in Australia. Because the number of studies on the topic of 
mortality forecasting in Australia is limited, the current study fills in the gaps in the 
literature. This research can be considered a great contribution to the existing literature, 
so that the projections obtained, without leaving aside the limitations of the 
methodologies used, are a complement to the set of official values. 
Some of the desirable attributes of a stochastic model are parsimony, 
robustness of forecasting, predicting positive mortality rates and flexibility (Congdon 
1993). Additionally, the ease with which all age groups can be incorporated in the 
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model is also seen as an advantage to demographers and actuaries (Heligman and 
Pollard 1980). In recent years, many user-friendly stochastic models have been 
developed to accommodate large datasets in different parts of the world, so as to give 
a more realistic estimate of lifespans over a wide range of demographics, while taking 
into account the uncertainties in the prediction (Aro and Pennanen 2011). The first of 
these was the model proposed by Lee and Carter (1992), which is an extension of the 
general linear model. While the Lee-Carter model remains the most commonly used 
model (Li, Hardy and Tan 2009), the use of multiple models has been shown to 
improve uncertainties surrounding mortality (Oeppen and Vaupel 2002).  
The Renshaw-Haberman model (Renshaw and Haberman 2003) was an 
extension of the Lee-Carter model with an added age cohort effect. The Cairns, Blake 
and Dowd model (2006b) was an extension of the Renshaw-Haberman wherein 
parametric uncertainty was incorporated. This enables demographers and actuaries to 
consider natural disasters and other extraneous factors contributing to trends in 
mortality (Dowd, Blake and Cairns 2016).  
The popularity of the Lee-Carter model and its extensions in the theoretical 
and empirical literature, as well as the extensive investigation of their limitations, 
represent reasons for applying this methodology in the current research. Thus, the 
analysis performed in this chapter involved applying the Lee-Carter model and five of 
its extensions (RH, APC, CBD, M7 and Plat) on Australian female mortality data 
between 1961 and 2011. Based on a comparison between the six models, the Lee-
Carter model has proved to be the most appropriate to forecast the female mortality 
rate and life-expectancy in Australia for the next 50 years. Results showed that the 
Lee-Carter model gave a comparatively good fit to the Australian data. 
In the empirical literature, many authors use performance measures such as 
the Mean Absolute Performance Error (MAPE) (Lee, Baek, Kim and Oh 2016), and 
the Mean Squared Error (MSE) and its derivative or the Root Mean Squared Error 
(RMSE) (Adhikari and Agarwal 2013) or both MAPE and RMSE (Husin, Zainol and 
Ramli, 2015) to evaluate the forecasting accuracy of a model. Other model selection 
methods commonly used in the literature are the AIC and the BIC criteria (Li et al. 
2009). Based on the common use of the RMSE in the existing empirical literature and 
taking into consideration its relative simplicity of use, this is one of the criteria used to 
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determine the goodness-of-fit for the Australian female dataset in the current study. 
The other two criteria used are the AIC and the BIC. 
The Lee-Carter forecasts of mortality rates are comparable to the official 
mortality rates, while the forecasts of life-expectancy are a little lower than official 
numbers, but the difference is not significant. On the other hand, experience has shown 
that the Lee-Carter method tends to under-predict life-expectancy (Lee and Miller 
2001: pp 537–549). Thus, the observed values of life-expectancy could even be higher 
than the Lee-Carter forecasts. 
Booth et al. (2006) applied the Lee-Carter model and its variants to forecast 
gender-specific mortality rates in ten different countries and concluded that deviation 
between models in predicting mortality rates did not extend to differences in 
calculating life-expectancy. In their study, they found that, while the more complex 
variants of the model were less prone to error, the strongest attributes of the original 
Lee-Carter model are its simplicity and robustness in forecasting linear trends. In their 
study, they did not study the effect of the length of the forecasting period on the 
forecast accuracy. 
In contrast with the analysis performed by Booth et al. (2006), the current 
study takes into consideration the effect of the fitting period (h). This was seen to have 
a significant effect on the RMSE and hence the predictive accuracy of the model. 
Short-term forecasts (e.g. h1) were more accurate than long-term predictions (e.g. 
h20). Moreover, based on the results of the RMSE for look forward windows, the 
comparison revealed that the Lee-Carter model is better suited for non–stratified data. 
In addition to the lowest error (RMSE) across almost all look forward windows, age-
based stratification and data sizes, the Lee-Carter model also had the lowest BIC and 
a low AIC. 
For the data set considered in the current study (different age cohorts, look 
forward windows and data size), the comparison techniques used revealed there are 
some notable differences amongst the six different models. However, none of the 
models analysed performs well in all tests and no model clearly dominates the others. 
This conclusion is consistent with the conclusion formulated by Dowd et al. (2010a) 
after assessing the goodness-of-fit of several mortality models applied to the English 
and Wales data. For the Australian female data set considered we find that the Lee-
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Carter model gives the lowest RMSE for all look forward windows and is better suited 
for non-stratified data. However, this model does not clearly stand out from the rest of 
the models analysed. The Plat model gave a comparatively good fit to the Australian 
female mortality data, while the Cairns-Blake-Dowd model gave the poorest fit to this 
data. 
While long-term forecasts are important for planning economic, social-
welfare and health objectives, short-term forecasts have enhanced application in 
identifying errors in long-term predictions (Booth et al. 2006). Using a variant of the 
Lee-Carter model, Lee and Miller (2001: pp 537–549) discovered that using a long-
term data to make a short-term forecast resulted in a jump-off error and a bias of 0.6 
years. This is because the random age effect in the model (𝛽𝑥) varies over time and 
the assumption that it is a constant leads to fallacious results, especially when fitting 
the model with extended historical data encompassing several decades.  
The comparison of the six stochastic models used in the current study 
revealed that the best-fitted models for the dataset were the Lee-Carter Model and the 
Plat model, based on the four selection criteria that quantify the goodness-of-fit and 
the parsimony of the models. On the same basis, the CBD model gave the poorest fit 
on all counts. However, when the data was fitted into both models to calculate 
mortality rates, the two models showed comparable results despite their differences. 
Similarly, life-expectancy was comparable between the Lee-Carter and CBD forecasts. 
For example, the mortality rate predicted by the Lee-Carter model for an 80-year-old 
Australian woman in 2011 is 0.034, while the CBD model predicted a mortality rate 
of 0.035 for the same individual. Also, using mortality rates predicted by the Lee-
Carter model, the residual life-expectancy for an Australia woman aged 80 in 2011, is 
10.23 while the CBD model gives a residual life-expectancy of 10.25 years, for the 
same individual. 
This comparability between the forecasts given by the Lee-Carter and CBD 
models is similar to the results obtained when the models were applied to the English 
and Wales male data. The CBD model gave the highest error and ranked poorly for 
the goodness-of-fit (Dowd et al. 2010a), but its forecasts were comparable to the ones 
given by the Lee-Carter model. The explanation behind this could be that the CBD 
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model is known to perform well for older cohorts, and produces realistically volatile 
results for older age groups, resulting in robust forecasts (Chan, Li, and Li 2014).  
In the current study, mortality rates were forecasted for women in Australia 
for a period of 1, 5, 10, 15, 20 and 50 years, using the CBD and Lee-Carter models. A 
cohort of 60–100 years was selected. Mortality rates obtained by both models showed 
a continued trend in declining mortality. The Lee-Carter model was more conservative 
in its prediction than the CBD model, estimating a steady fall in mortality rates from 
0.004 in 2011 to a predicted 0.003 in 2021. With the CBD model, mortality rates 
declined from 0.0025 in 2011 to 0.00188 in 2021. Further forecasting indicated a 
further decline to 0.0014 for the Lee-Carter model and 0.0059 for the CBD model in 
2061. Based on this forecast it is likely that the number of women over 60 years of age 
could increase by 25% by 2021. 
Clearly, the forecasting results obtained in the current study indicate that in 
the long-term there is a decreasing trend in mortality rates and an increasing trend in 
life-expectancy for the Australian female population. These forecasts are consistent 
with the results obtained by other authors (for example, the studies of Li et al. (2009); 
Booth (2004); Cairns et al. (2011); Hollmann, Mulder and Kallan (1999); Debón, 
Montes and Puig (2008)).  
As demonstrated by of Booth et al. (2006), the Lee-Carter model and its 
extensions have a tendency to underestimate errors for the younger ages (0–40) and 
overestimate them for higher age-groups (60–100). However, the life-expectancy 
calculated by the Lee-Carter model, which had a low RMSE (0.002) did not 
significantly differ from the life-expectancy calculated by the CBD model, in which 
the error was notably overestimated with RMSE of 0.02. Hence, the current study 
agrees with Booth’s hypothesis that the level of error in the model does not translate 
into an erroneous estimation of life-expectancy (Booth et al. 2006). 
The results obtained after applying the Lee-Carter and CBD models suggest 
that female mortality in Australia has been decreasing in the last decades and, looking 
at the mortality rates forecasts for the next 50 years, it can be concluded that this 
population factor will continue to decrease. One of the implications of this research 
for practice is that the implementation of a model such as the Lee-Carter model for the 
demographic information of a country can suggest population dynamics that allow 
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revising the formulations that base the models for pension and insurance funds. Under 
the assumption that insurance and pension companies are regionally concentrated, it 
would be interesting for future research purposes to conduct a study that differentiates 
the mortality rates by regions. This may suggest a differential risk per region and 
therefore higher or lower pension costs for different participants in the sector. 
Even though some previous studies in the literature have proved that in 
general the more complex variants of the Lee-Carter are less prone to error, the best-
fitted model for the Australian female data has proved to be the basic Lee-Carter 
model. Thus, the main implication for research is the suggestion that none of the 
models analysed performs well in all tests and no model clearly dominates the others. 
Furthermore, this research disclosed further research paths concerning mortality rate 
analysis in Australia, which may help in fostering research on this topic. 
The contributions and implications of this research are logical to consider that 
mortality and life-expectancy in Australia will continue to improve gradually over 
time, due to a variety of factors, rather than experiencing a substantial abrupt 
improvement. Among these factors might be great medical advances, greater access to 
health, reductions in tobacco consumption, etc. 
3.9 Conclusion  
It has been estimated that, in the last 60 years, female life-expectancy in Australia has 
been increasing at a steady rate of 3 months every year (Oeppen and Vaupel 2002). 
The increasing trends in life-expectancies in general have led some demographers to 
assume that human lifespans could become unlimited (Tuljapurkar et al. 2000). Then 
again, others have argued that the declining mortality trends may level off, owing to 
factors such as obesity (Olshansky, Carnes and Désesquelles 2001), lifestyle 
deterioration (Loladze 2002) and environmental factors (Olshansky, Passaro, 
Hershow, Layden, Carnes, Brody, Hayflick, Butler, Allison and Ludwig 2005).  
From the present study, based on the results of the RMSE for various look 
forward windows, it may be inferred that the Lee-Carter model and Plat model are 
more suited to fit a non–stratified model for ages 0 to 100 (See Tables 3.3–3.6). Results 
across all look back windows are comparable, hence for computational convenience the data 
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20 can be used to model mortality for ages 60 to 100 or 80 to 100, and this is an improvement 
over the model for all ages (See Tables 3.10 and 3.13). 
The current study concurs with arguments in favour of long-term declining 
trends in mortality, as the degree of uncertainty with which these predictions are made, 
is not well defined. Although the selection of mortality models is based on statistical 
criteria, additional considerations such as flexibility and robustness of forecasting are 
features that need to be considered in choosing the best stochastic model for predicting 
human mortality.  
Most studies in mortality modelling are calibrated for male populations 
(Dowd et al. 2010a). The current study is a focus on the female population, and 
continuing trends in higher survival rates of women would necessitate a review of the 
financial and healthcare systems. These departments would, in turn, need to remodel 
themselves to cope with higher numbers of single or widowed older women, solely 
dependent on state welfare and an over-extended social security system. 
The following chapter dedicated to comprehensively examine the mortality 
of just the Australian male. 
 
 73 
Chapter 4 Analysis of Australian Male Mortality 
4.1 Introduction 
Life-expectancy in Australia has changed significantly over the last 60 years for both 
males and females (Section 2.4.1). Over this period, male life-expectancy at birth has 
increased by more than ten years.  
In this chapter we comprehensively examine the mortality of Australian male. 
Figure 4.1 below illustrates the evolution of male life-expectancy in Australia, Russia, 
Sweden, China, Israel, India, Libya, Sub-Saharan Africa, and the world between 1960 
and 2014. There is an increase in worldwide male longevity from 52.4 years in 1960 
to 71.4 years in 2014. In Australia, male life-expectancy increased from 70.8 years in 
1960 to 85.2 in 2014. Similarly, there has been an increasing trend in male life-
expectancy in countries mentioned above, over the last 54 years. 
 
Figure 4.1 Male life-expectancy for Australia and the World - 1960 –2014.  
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4.2 Objectives and Research Methodology 
The main objectives of this chapter are to compare the fit of the six stochastic mortality 
models discussed in section 2.4.2 and to identify the model that is best suited to model 
Australian male mortality rates and life-expectancy. The comparison is based on 
selection criteria encompassing goodness-of-fit and parsimony of the model. 
The research methodology is the same as section 3.5 and is not repeated here. 
The modelling results for h=1, Data 20 for LC model (similar to Table 3.2) are 
presented in Table 4.1. A selection of the results is presented in Appendix B, Table 
B.6–Table B.10.  
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Table 4.1 The results of the goodness of fit criteria of data 20 and h=1 using LC model, Australian male. 
 Age Full Age Stratified 
  Scenario 1 Scenario 2 
LC S0 S1A S1B S1C S2A S2B S2C 




























































































































 Age Full Age Stratified 
  Scenario 1 Scenario 2 
LC S0 S1A S1B S1C S2A S2B S2C 


















































































l: look back window 20–years 
t: year of prediction 
[t–h– l, t–h]: modelling time 
Scenario 0 (S0): [0–100] 
Scenario 1 (S1): S1A=[0–40], S1B=[40–60], S1C=[60–100] 
Scenario 2 (S2): S2A=[0–60], S2B=[60–80], S2C=[80–100] 
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As mentioned in section 3.5, the fitting of male mortality data for some 
scenarios using R, package StMoMo was challenging.  There was converge issues, 
largely due to the default choice of ARIMA (0, 0, 1). In some cases choice of ARIMA 
(1, 1, 0) model or other form resolved the issues.  In other cases, especially with M7 
and RH models, reasonable fits could not be obtained. These cases are then not 
included in subsequent comparisons.  
4.3 Results 
The following sections present the comparisons of the average RMSE values for the six 
mortality models for different look back windows, look forward windows and age 
stratification. Each section corresponds to each age stratification, namely S0, S1 and S2. 
4.3.1 Comparison of average RMSE for different look back and look 
forward windows for Scenario S0 
The following sections will present the comparisons of the average RMSE for the six 
models for different look back, look forward windows under non-stratified data 
(Scenario S0, ages: 0:100) using Australian males data. 
First, we consider Data20, which is 20 years look back window. RMSE is 
computed for each of the six models (Lee-Carter, RH, APC, CBD, M7 and Plat) and 
five look forward windows (h=1, h=5, h=10, h=15 and h=20).  The results are 
presented in Table 4.2. 
Table 4.2 Average RMSE, Look back Window =20 years, Ages: 0–100, Australian male. 
 
Look Forward Window 
Model h=1 h=5 h=10 h=15 h=20 
LC     0.007053     0.008151     0.016352     0.014889      0.018894 
RH     0.022115     0.100593     0.047853     0.036723      0.088449 
APC     0.007470     0.012341     0.015663     0.021075      0.028446 
CBD     0.027415     0.025969     0.023423     0.015227      0.017157 
M7     0.024462     0.044227     0.067026     0.089023      0.102262 
Plat     0.006912     0.009109     0.014839     0.017061      0.022196 
P-value      0.0000      0.0002     0.0000     0.0000     0.0000 
Each cell in the table presents average RMSE for prediction years 2007–2011.  
P-values reported in the last row are from one-way ANOVA model followed Tukey’s HSD pairwise 
comparisons where appropriate. Groups with lowest and similar average RMSE are presented in bold. 
Red highlight is the case with smallest RMSE. 
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As evident from the Table 4.2, Australian male's results are comparable to 
Australian female's results for the average root mean square error. The smallest 
average error for all models is given by the 1-year look forward window, while the 
highest average RMSE is given by the 20-year look forward window. The average root 
mean square error increases with an increase in the value of h. 
A single factor analysis of variance (ANOVA) comparing average RMSE 
across models for h=1, indicate that average RMSE for models is not the same. Similar 
results are observed for value of h=5, 10, 15, 20. 
LC and Plat models obtained the lowest RMSE values for different look 
forward windows. For h=1 and h=5, performance of LC and Plat are comparable, while 
for h=15 and h=20 performance of LC, Plat and CBD are comparable. Meanwhile, for 
h=10, performance of LC, Plat and APC are comparable. 
Secondly Data30, which is 30 years look back window was investigated. 
Table 4.3 below is the results of average RMSE of the six stochastic models and five 
different look forward windows fitted under non-stratified data, ages 0–100. 
Table 4.3 Average RMSE, Look back Window =30 years, Ages: 0–100, Australian male 
 
Look Forward Window 
Model h=1 h=5 h=10 h=15 h=20 
LC     0.007700   0.009098   0.013127    0.013841    0.017470 
RH     0.040990   0.059602   0.057581    0.099908    0.108796 
APC     0.009197   0.015932   0.021814    0.023412    0.024006 
CBD     0.027204   0.025182   0.023241    0.012879    0.011172 
M7     0.028952   0.051942   0.078188    0.095815    0.105402 
Plat     0.007285   0.011408   0.019275    0.016604    0.016213 
P-value     0.0000   0.0000   0.0000    0.0000    0.0000 
Each cell in the table presents average RMSE for prediction years 2007–2011.  
P-values reported in the last row are from one-way ANOVA model followed Tukey’s HSD pairwise 
comparisons where appropriate. Groups with lowest and similar average RMSE are presented in bold. 
Red highlight is the case with smallest RMSE. 
As expected, the errors are higher for a higher look forward window. The 
smallest average error for all models is given by the 1-year look forward window while 
the highest average RMSE is given by the 20-year look forward window. 
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A one-way ANOVA for RMSE comparing average RMSE across models for 
each look forward window, indicate that average RMSE for models is not the same for 
each look forward window. 
For different look forward windows LC model results in lowest RMSE 
values. The next comparable model is Plat Model for all look forward windows. 
For h=5 and h=10, the performance of LC, Plat, CBD and APC are 
comparable, meanwhile, for h=15 and h=20, the performance of LC, Plat and APC are 
comparable. For h=1, performance for LC and Plat model are comparable. 
Thirdly, we examine results for Data40. The RMSE is computed for each of 
the six stochastic models and five look forward windows (h=1, h=5, h=10, h=15 and 
h=20) under the non-stratified data ages: 0–100. The results are presented in Table 4.4 
Table 4.4 Average RMSE, Look back window=40 years, ages: 0–100, Australian male. 
 
Look Forward Window 
Model h=1 h=5 h=10 h=15 h=20 
LC     0.007782     0.009292     0.012441     0.013077     0.016728 
RH     0.017953     0.038867     0.023918     0.093303     0.097766 
APC     0.012939     0.019791     0.022754     0.023863     0.024411 
CBD     0.027151     0.024134     0.018610     0.010296     0.013295 
M7     0.032966     0.059969     0.085493     0.100702     0.108059 
Plat     0.008856     0.013347     0.018047     0.015097     0.016097 
P-value     0.0000     0.0001     0.0000     0.0000     0.0054 
Each cell in the table presents average RMSE for prediction years 2007–2011.  
P-values reported in the last row are from one-way ANOVA model followed Tukey’s HSD pairwise 
comparisons where appropriate. Groups with lowest and similar average RMSE are presented in bold. 
Red highlight is the case with smallest RMSE. 
Table 4.4 above shows increasing error and decreasing goodness-of-fit with 
increasing values of ‘h’. The minimum RMSE is 0.00778 given by the 1-year look 
forward window using LC model and the maximum RMSE is 0.1081 given by the 20-
year look forward window using M7 model. As expected, the error is higher for a 
higher look forward window. 
A one-way ANOVA for RMSE comparing average RMSE across models for 
each look forward window indicates that the average RMSE for the models is not the 
same for each look forward window.   
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For h=1, performance of LC, Plat and APC are comparable, while for h=10 
and h=20, the performance of all the models are comparable except M7. Meanwhile, 
for h=15, the performance of LC, Plat and CBD are comparable, whilst for h=5 the 
performance of LC, Plat, APC and CBD are comparable. 
Finally, Table 4.5 below shows the comparative RMSE for different look 
forward windows for the six mortality model, fitted using non–stratified data for the 
ages 0–100 years using look back window 50-years. 
Table 4.5 Average RMSE, Look back window=50 years, ages: 0–100, Australian male. 
 
Look Forward Window 
Model h=1 h=5 h=10 h=15 h=20 
LC     0.007800    0.008882    0.012038    0.013841    0.016641 
RH     0.013652    0.042924    0.010439    0.099908    11.743798 
APC     0.016384    0.022114    0.024087    0.023412     0.022876 
CBD     0.026768    0.022547    0.016738    0.012879     0.017814 
M7     0.036162    0.066781    0.091420    0.095815     0.111108 
Plat     0.010978    0.014783    0.018467    0.016604     0.014390 
P-value     0.0000    0.0000    0.0000    0.0000     0.0000 
Each cell in the table presents average RMSE for prediction years 2007–2011.  
P-values reported in the last row are from one-way ANOVA model followed Tukey’s HSD pairwise 
comparisons where appropriate. Groups with lowest and similar average RMSE are presented in bold. 
Red highlight is the case with smallest. 
As is evident from the Table 4.5, the average RMSE increases with an 
increase in the value of h. The smallest average error for all models is given by the 1–
year look forward window, while the highest average RMSE is given by the 20–year 
look forward window.  
A single factor analysis of variance (ANOVA) comparing average RMSE 
across models, shows that for each look forward windows, the average RMSE criterion 
varied significantly between all models (p-value<0.05).   
For h=5 and h=15, performances of LC, Plat and CBD models are 
comparable, while for h=1, performances of LC and Plat are comparable. Meanwhile, 
for h=10, performances of LC and RH are comparable, whilst for h=20, performances 
of the six models are comparable. 
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To understand the sensitivity of length of data required for forwarding 
prediction, the best performing model is selected for each h, and the average RMSE is 
compared for each decade of data acquisition. The results are presented in Figure 4.2 
 
Figure 4.2 RMSE for the different look back and look forward windows, ages: 0–100 
years, Australian male. 
For each value of h, one-way ANOVA comparing average RMSE across 4 
decades of look back window resulted in P-value greater than 0.05, indicating equality 
of mean. There is not much improvement in RMSE as additional 10 years of modelling 
data is used. Consequently, keeping data acquisition simple, 20 years of data can be 
safely used for modelling. This is consistent with the modelling of female mortality data.  
The final summary of the best performing modelling method and look back 
window is presented in Table 4.6. 
Table 4.6 Summary of the best of look back and look forward windows using mortality 
models, S0. 
Forward prediction Modelling method Look back window 
h=1 LC and Plat 20 years or more 
h=5 LC and Plat 20 years or more 
h=10 LC 20 years or more 
h=15 LC, Plat and CBD 20 years or more 
h=20 LC, Plat and CBD 20 years or more 
 
In the following sections we only focus on Data20 for parsimony and 












RMSE values for the different lookback windows, 
ages: 0-100 years, Australian male
Data20 Data30 Data40 Data50
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4.3.2 Comparison of average RMSE for different look forward 
windows for stratified data (Scenario S1) 
This section will present the comparisons of the average RMSE for the six 
models for different look forward windows with stratified data under second scenario 
(Scenario S1, ages: 0:40, 40:60, 60:100) using look back window 20-years only. 
To begin with, the second scenario S1 with age-group 0–40. A summary of 
the average RMSE for the different age cohorts is illustrated in Table 4.7 below. 
Table 4.7 Average RMSE, Look back window=20 years, ages: 0–40, Australian male. 
 
Look Forward Window 
Model h=1 h=5 h=10 h=15 h=20 
LC     0.000084 0.000192 0.000293 0.000309 0.000358 
RH     0.000084 0.000556 0.005832 0.000153 0.000362 
APC     0.000080 0.000071 0.000112 0.000145 0.000210 
CBD     0.000703 0.000701 0.000729 0.000734 0.000731 
M7     0.001120 0.003415 0.053159 0.976010 15.588462 
Plat     0.000077 0.000101 0.000238 0.000239 0.000192 
P-value     0.0000 0.0000 0.0000 0.0000 0.0000 
Mean     0.0001 0.0001 0.0001 0.0001 0.0002 
t-Statistics     –0.5200 –3.4524 –6.1107 –3.0209 –0.5051 
P(T<=t)     0.3153 0.0130 0.0018 0.0196 0.3200 
Each cell in the table presents average RMSE for prediction years 2007–2011. 
P-values reported are from one-way ANOVA model followed Tukey’s HSD pairwise comparisons where 
appropriate. Groups with lowest and similar average RMSE are presented in bold. The Means, t-Statistics 
and P (T<=t) in the last three rows are from paired t-test for comparing RMSE from best performing model 
under S1 and S0 for corresponding ages. Red highlight is the case with smallest RMSE. 
The model with the best fit for this dataset for short-term and long-term 
forecasting (h =1 and h=20) was the Plat model follow by APC Aand LC models (See 
Table 4.7). 
One way ANOVA for RMSE comparing models shows that there is a significant 
variation in the goodness-of-fit by average RMSE within the five different look 
forward windows (p-value<0.05). 
A student’s t-test to compare the average RMSE and average RMSES0 values 
shows that comparable results are obtained for age strata S1A if we model age group 
0–100 years or 0–40 for look forward window h=1 and 20. On the other hand, for look 
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forward windows h=5, 10, and 15 smaller RMSE are obtained if we model age groups 
0–40 years instead of 0–100 years (P<0.01) (See Table 4.7) 
Second, we consider age-group 40–60, using data 20. RMSE is computed for 
each of the six models (Lee-Carter, RH, APC, CBD, M7 and Plat) and five look forward 
windows (h=1, h=5, h=10, h=15 and h=20).  The results are presented in Table 4.8 
Table 4.8 Average RMSE, Look back window=20 years, ages: 40–60, Australian male. 
 
Look Forward Window 
Model h=1 h=5 h=10 h=15 h=20 
LC     0.000223 0.000418 0.000588 0.000656 0.000673 
RH     0.000427 0.000217 0.000347 0.001418 0.003401 
APC     0.000197 0.000217 0.000246 0.000298 0.000522 
CBD     0.000220 0.000443 0.000588 0.000597 0.000573 
M7     0.000208 0.000439 0.000546 0.000475 0.000624 
Plat     0.000207 0.000396 0.000493 0.000340 0.000576 
P-value     0.5594 0.0000 0.0000 0.1374 0.0001 
Mean     0.0002 0.0002 0.0004 0.0005 0.0009 
t-Statistics     –2.1123 0.2553 13.7764 6.6593 2.6636 
P(T<=t)     0.0511 0.4055 0.0001 0.0013 0.0281 
Each cell in the table presents average RMSE for prediction years 2007–2011.  
P-values reported are from one-way ANOVA model followed Tukey’s HSD pairwise comparisons where 
appropriate. Groups with lowest and similar average RMSE are presented in bold. The Means, t-Statistics 
and P (T<=t) in the last three rows are from paired t-test for comparing RMSE from best performing model 
under S1 and S0 for corresponding ages. Red highlight is the case with smallest RMSE. 
For h=1 and 15 forecasting performance of all modelling methods are 
comparable. For h=5, 10 and 20 the APC  and RH comparable and best performing models. 
A student’s t-test to compare the average RMSE and average RMSES0 values 
shows that comparable results are obtained for age strata S1B if we model age group 
0–100 years or 40–60 years for look forward windows h=1 and 5. On the other hand, 
for look forward windows of 10 or more years, smaller RMSE are obtained if we model 
age groups 40–60 years instead of 0–100 years (P<0.01) (See Table 4.8). 
Finally, Table 4.9 below show the comparative RMSE for different look 
forward windows for the six mortality model, fitted using scenario S1 data for the ages 
60–100 years. 
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Table 4.9 Average RMSE, Look back window=20 years, ages: 60–100, Australian male. 
 
Look Forward Window 
Model h=1 h=5 h=10 h=15 h=20 
LC       0.011080 0.012699 0.025896 0.023120 0.029113 
RH       0.020474 0.142091 0.095944 0.086075 0.063505 
APC       0.011443 0.018429 0.025205 0.033550 0.043604 
CBD       0.018196 0.022285 0.030235 0.029740 0.034221 
M7       0.014901 0.014491 0.012285 0.018481 0.027721 
Plat       0.010871 0.011178 0.011292 0.016169 0.020636 
P-value       0.2054 0.0000 0.0000 0.0008 0.0026 
Mean       0.0108 0.0108 0.0233 0.0268 0.0348 
t-Statistics      –0.0332 –0.4311 5.4475 2.6829 1.5863 
P(T<=t)       0.4875 0.3443 0.0028 0.0275 0.0939 
Each cell in the table presents average RMSE for prediction years 2007–2011.  
P-values reported are from one-way ANOVA model followed Tukey’s HSD pairwise comparisons where 
appropriate. Groups with lowest and similar average RMSE are presented in bold. The Means, t-Statistics 
and P (T<=t) in the last three rows are from paired t-test for comparing RMSE from best performing model 
under S1 and S0 for corresponding ages. Red highlight is the case with smallest RMSE. 
Table 4.9, clearly shows that the Plat, Lee-Carter and M7 models give the 
lowest average RMSE values and that the RH model gives the highest average RMSE 
values for all look forward windows. The modeling method with the best fit for this 
dataset for all look forward windows is the Plat model. 
A one-way ANOVA for average RMSE across models shows that for look 
forward windows of 5 year or more, the average RMSE criterion varied significantly 
between all models (p-value<0.05). 
A student’s t-test to compare the average RMSE and average RMSES0 values 
shows that comparable results are obtained, for age strata S1C if we model age group 
0–100 years or 60–100 years for h=1, 5, 15 and 20. On the other hand, for look forward 
windows h=10 smaller RMSE are obtained if we model age groups 60–100 years 
instead of 0–100 years (P<0.01) (See Table 4.9) 
The following is a comparison of the average RMSE values for the six models 
for all age cohort groups of the third scenario for different look forward windows. 
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4.3.3 Comparison of average RMSE for different look forward 
windows for stratified data (Scenario S2) 
Further stratification of data in scenario (S2) for stratified age data is 
(Scenario S2: A=0–60, B=60–80, C=80–100). Tables 4.10–4.12 are the summary of 
the goodness-of-fit in terms of RMSE between different look forward windows for the 
six different models using Data 20-years under the third scenario S2. 
Table 4.10 Average RMSE, Look back window=20 years, ages: 0–60, Australian male. 
 
Look Forward Window 
Model h=1 h=5 h=10 h=15 h=20 
LC      0.000176 0.000318 0.000417 0.000461 0.000521 
RH      0.000506 15770 225644861 0.017645 0.003554 
APC      0.000135 0.000165 0.000243 0.000354 0.000549 
CBD      0.000711 0.000774 0.000869 0.000866 0.000761 
M7      0.000896 0.001212 0.001640 0.002207 0.005382 
Plat      0.000126 0.000138 0.000262 0.000394 0.000599 
P-value      0.0051 0.0185 0.4154 0.4629 0.0001 
Mean      0.0001 0.0001 0.0003 0.0004 0.0007 
t-Statistics      0.2647 0.1293 0.0348 1.8581 2.1248 
P(T<=t)      0.4022 0.4517 0.4869 0.0683 0.0504 
Table 4.11 Average RMSE, Look back window=20 years, ages: 60–80, Australian male. 
 
Look Forward Window 
Model h=1 h=5 h=10 h=15 h=20 
LC       0.000985 0.001005 0.002327 0.004492 0.006251 
RH       0.001030 0.008218 0.002669 0.005529 0.003891 
APC       0.001010 0.001555 0.001407 0.001589 0.003149 
CBD       0.001217 0.000998 0.002347 0.004302 0.006313 
M7       0.000960 0.000998 0.002821 0.004513 0.006533 
Plat       0.000978 0.001026 0.002483 0.004503 0.006918 
P-value       0.3881 0.0238 0.4405 0.0004 0.0013 
Mean       0.0009 0.0014 0.0011 0.0011 0.0022 
t-Statistics       –2.1483 –3.8087 –2.7619 –6.2329 –1.9425 
P(T<=t)       0.0491 0.0095 0.0254 0.0017 0.0620 
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Table 4.12 Average RMSE, Look back window=20 years, ages: 80–100, Australian male. 
 
Look Forward Window 
Model h=1 h=5 h=10 h=15 h=20 
LC       0.015491 0.017684 0.034903 0.028538 0.036265 
RH       0.046805 0.212568 0.241935 0.161524 0.150989 
APC       0.015246 0.020968 0.031371 0.044432 0.049402 
CBD       0.028128 0.038309 0.041721 0.031483 0.040538 
M7       0.013835 0.017871 0.023784 0.031847 0.045663 
Plat       0.015143 0.016434 0.017029 0.033037 0.036372 
P-value       0.0002 0.0000 0.0000 0.0003 0.0012 
Mean       0.0151 0.0199 0.0325 0.0374 0.0485 
t-Statistics       –0.0248 1.2459 5.4467 0.4116 1.6064 
P(T<=t)       0.4907 0.1404 0.0028 0.3509 0.0917 
Each cell in the table presents average RMSE for prediction years 2007–2011.  
P-values reported are from one-way ANOVA model followed Tukey’s HSD pairwise comparisons 
where appropriate. Groups with lowest and similar average RMSE are presented in bold. The Means, 
t-Statistics and P (T<=t) in the last three rows are from paired t-test for comparing RMSE from best 
performing model under S1 and S0 for corresponding ages. Red highlight is the case with smallest 
RMSE. 
Table 4.10–Table 4.12 above show clearly for both short-term (h=1, 5) and 
long-term (h=15, 20) forecasting performance of  LC and Plat modelling methods are 
comparable. For  h=10, APC, M7 and Plat are comparable and best performing models. 
The model with the poorest fit for this age cohort was the RH model for almost all 
look forward windows. 
A student’s t-test to compare the average RMSE and average RMSES0 values 
shows that comparable results should be obtained if we model age group 0–100 years 
than 0–60 years for all h values. On the other hand, for look forward windows h=5 and 
15 smaller average RMSE are obtained if we model age groups 60–80 years instead of 
0–100 years; likewise, for h=10, age groups 80–100 years (P<0.01) (See Tables 4.10–
4.12). 
4.3.4 Comparison of average AIC and BIC for different scenarios     
The purpose of this section of this section is to illustrate that the best performing 
models on RMSE are also good performing models using the AIC and BIC criterion.  
The comparisons between the average AIC and BIC values for 15-year look 
forward window using look back window 20-years are illustrated in Figure 4.3–4.9 
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below. The comparison shows that the best fitted models for scenario S0 (0–100 years, 
non–stratified data) are (Plat, LC, and APC) also have lower AIC and BIC values.  
  
Figure 4.3 A comparative assessment of the six mortality models with respect to S0 for 
ages 0–100, h=15, Data 20. 
Figure 4.4 below shows that once again for scenario S1A (0–40 years) the best 
fitted model according to RMSE (Plat, APC, RH and LC) are also the models with 
lower AIC and BIC values.  
For the same scenario, stratified data 40–60 years, the Renshaw-Haberman and 
the APC models give the best results according to the AIC and RMSE criteria, while 
according to the BIC criterion the Lee-Carter models and APC are the best fitted model 
for this dataset (Figure 4.5 below). However, AIC and BIC values for best performing 
models for RMSE (all modelling methods) are comparable to the best scenario.  
Figure 4.6 below, presents AIC and BIC values for S1C (60–100 years). Once 




















Average AIC and BIC for six stochastic models for 
data size 20,  h=15, S0 (0-100)
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Figure 4.4 A comparative assessment of the six mortality models with respect to S1 for 
ages 0–40, h=15, Data 20. 
 
Figure 4.5 A comparative assessment of the six mortality models with respect to S1 for 
ages 40–60, h=15, Data 20. 
 
Figure 4.6 A comparative assessment of the six mortality models with respect to S1 for 
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For scenario S2A (0–60 years), data 20, 15–year look forward window, the 
results show that according to the AIC criterion the best fitted models are the Plat and 
the RH models. The BIC and RMSE criteria give the Plat and the APC models as the 
best models to estimate mortality and life-expectancy rates for this dataset. The M7, 
CBD and the APC models are the best fitted models for scenario S2B (60–80 years) 
according to the AIC and the BIC criterion, while according to RMSE the M7 and Plat 
models are the best. Finally, for scenario S2C (80–100 years) the AIC criterion gives 
the APC and M7 models as the best fitted models, the BIC criterion gives the Lee-
Carter and the APC models, while the minimum RMSE values are given by the Plat 
and the M7 models (Figure 4.7–4.9 below). 
 
Figure 4.7 A comparative assessment of the six mortality models with respect to S2 for 
ages 0–60, h=15, Data 20. 
 
Figure 4.8 A comparative assessment of the six mortality models with respect to S2 for 
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Data20,  h=15, S2 (0-60)






















AIC and BIC for six stochastic models for data size 
Data20,  h=15, S2 (60-80)
LC APC CBD RH M7 Plat
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Figure 4.9 A comparative assessment of the six mortality models with respect to S2 for 
ages 80–100, h=15, Data 20. 
Overall, the best performing models for RMSE (LC and Plat) have lower AIC 
and BIC values. This is consistent with the modelling of female mortality data. 
4.3.5 Randomness of residuals 
The fourth criterion to be satisfied for model selection is the randomness of 
residuals. The scatter plot of the residuals for the six models shows they are disordered 
and do not show any pattern, which means they are randomly distributed.  
Figure 4.10 shows that the distribution of residuals for the Lee-Carter model 
is random and indicates deterioration in mortality (red cells). The decline in mortality 
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Figure 4.10 Residual plot for the Lee-Carter model. 
 
Figure 4.11 Parameter estimation for Lee-Carter model. 
Figure 4.11 above shows the plots of the estimated age-coefficients 𝛼𝑥 and 
𝛽𝑥 reflecting age-related effects, and the mortality index 𝑘𝑡, reflecting time-related 
effects. Typical for the Lee-Carter model, these coefficients follow exponential and 
linear trends, with: 
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 coefficient 𝛼𝑥 independent of time;   
 coefficient 𝛽𝑥 reflecting how rapidly or slowly mortality at each age changes 
when the mortality rate changes and  
 Coefficient 𝑘𝑡 showing the general level of mortality rate. 
 No issues with residuals was noted for best performing cases of RMSE. 
4.3.6 Summary of results 
Based on the analysis performed in the previous sections of this chapter, the 
following assumptions can be made about the model selection. 
According to the four criteria for model selection, the Lee-Carter model is the 
best-fitted model to the dataset (Data 20, age cohort 60–100). In addition to the lowest 
error (RMSE) across most of the look forward windows, low values across age-based 
stratification also had the lowest BIC values and low AIC values. Results showed there 
was no significant difference in the goodness-of-fit for the Australian male mortality 
data, between the different data sizes (Data 20 to Data 50) for the six stochastic models 
studied. Furthermore, a significant difference was detected in all the quantitative criteria 
across the look back windows (or the length of the forecast, h=1, h=5, h=10, h=15). 
In conclusion, the Lee-Carter and Plat models are the best model for 
estimating male mortality rates and life-expectancy. The CBD and M7 models had the 
highest values for the RMSE as well as BIC and AIC, suggesting a poor selection for 
this dataset.  
4.4 Calculating mortality 
The estimated mortality rates and number of deaths from the Lee-Carter model and 
CBD model are tabulated in Table 4.13. Calculated life-expectancy using mortality 
rates from both models and population data from life-tables (www.mortality.org) is 
presented in Table 4.14. 
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Table 4.13 Mortality rate [𝒎(𝒙,𝒕)] and number of deaths [𝑫(𝐱,𝒕)] computed by the CBD 
and Lee-Carter Models and original Australian male data for year 2011, ages 
60–100. 
 
Mortality rate [𝒎(𝒙,𝒕)]  Number of deaths [𝑫(𝒙,𝒕)] 
Age  CBD LC original CBD LC original  
60 0.005302 0.00608 0.00678 658.7804 755 619 
61 0.005972 0.00674 0.00762 728.1093 822 691 
62 0.006726 0.007253 0.00793 808.7256 872 714 
63 0.007576 0.008104 0.00882 919.252 983 787 
64 0.008533 0.008891 0.00984 1016.752 1059 870 
65 0.00961 0.009938 0.01031 1051.369 1087 902 
66 0.010824 0.011489 0.01171 1091.423 1158 1014 
67 0.012192 0.012492 0.01293 1155.029 1184 1105 
68 0.013732 0.013686 0.01366 1213.294 1209 1152 
69 0.015466 0.015182 0.01503 1295.743 1272 1250 
70 0.01742 0.017236 0.01644 1385.673 1371 1346 
71 0.01962 0.019241 0.01879 1479.44 1451 1511 
72 0.022098 0.021123 0.02172 1580.31 1511 1712 
73 0.02489 0.023582 0.02306 1678.661 1590 1777 
74 0.028034 0.026437 0.02716 1782.382 1681 2042 
75 0.031575 0.029464 0.02909 1866.944 1742 2126 
76 0.035563 0.033197 0.03372 1944.829 1815 2388 
77 0.040055 0.038407 0.03881 2050.864 1966 2651 
78 0.045115 0.041834 0.04109 2181.727 2023 2697 
79 0.050814 0.048111 0.04808 2343.998 2219 3018 
80 0.057232 0.054856 0.05327 2535.562 2430 3179 
81 0.064462 0.063066 0.06018 2689.656 2631 3393 
82 0.072604 0.069903 0.06828 2781.616 2678 3611 
83 0.081775 0.079087 0.07754 2839.255 2746 3813 
84 0.092105 0.088398 0.0871 2861.583 2746 3945 
85 0.103739 0.101103 0.0979 2838.844 2767 4043 
86 0.116843 0.111997 0.11403 2776.782 2662 4237 
87 0.131602 0.125655 0.11935 2647.618 2528 3946 
88 0.148225 0.14093 0.13756 2494.539 2372 4002 
89 0.166949 0.159452 0.161 2311.432 2208 4037 
90 0.188037 0.182115 0.17951 2065.738 2001 3798 
91 0.211789 0.202353 0.2063 1698.029 1622 3601 
92 0.238541 0.225155 0.21326 1319.9 1246 3017 
93 0.268672 0.248302 0.2464 1106.772 1023 2773 
94 0.30261 0.274512 0.28028 938.2485 851 2425 
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Mortality rate [𝒎(𝒙,𝒕)]  Number of deaths [𝑫(𝒙,𝒕)] 
Age  CBD LC original CBD LC original  
95 0.340834 0.307899 0.30273 739.8596 668 1956 
96 0.383887 0.326042 0.33251 576.111 489 1564 
97 0.432378 0.378175 0.36369 425.3694 372 1207 
98 0.486994 0.383811 0.39606 300.4901 237 897 
99 0.548509 0.388653 0.42937 196.6516 139 642 
100 0.617795 0.467283 0.46333 123.1389 93 442 
Table 4.14 Calculation of life-expectancy of Australian male from modelled mortality rates 
for year 2011, ages 60–100. 
 
Number of survivors [𝒍𝒙]  
Life-expectancy [𝒆(𝒙,𝒕)] 
Age  CBD LC (Original) 𝑻𝒙 (original) CBD LC (Original) 
60 90972.22 90876 91631 2132822 23.444762 23.4697 23.28 
61 90283.891 90190 91012 2041501 22.612018 22.635519 22.43 
62 89512.274 89449 90321 1950834 21.794039 21.809479 21.6 
63 88687.748 88624 89607 1860870 20.982267 20.997437 20.77 
64 87804.248 87762 88821 1771656 20.177338 20.187165 19.95 
65 86899.631 86864 87951 1683270 19.370278 19.378278 19.14 
66 85956.577 85890 87048 1595771 18.564851 18.579348 18.33 
67 84879.971 84851 86035 1509229 17.780744 17.786711 17.54 
68 83716.706 83721 84930 1423747 17.006725 17.005907 16.76 
69 82481.257 82505 83777 1339393 16.238756 16.234071 15.99 
70 81142.327 81157 82528 1256241 15.481944 15.479154 15.22 
71 79702.56 79731 81182 1174386 14.734608 14.729323 14.47 
72 78089.69 78159 79670 1093960 14.00902 13.996515 13.73 
73 76280.339 76369 77959 1015146 13.308095 13.29273 13.02 
74 74399.618 74501 76182 938076 12.608613 12.59143 12.31 
75 72273.056 72398 74140 862915 11.93965 11.919068 11.64 
76 70069.171 70199 72014 789838 11.272261 11.251483 10.97 
77 67575.136 67660 69626 719018 10.640275 10.627006 10.33 
78 64794.273 64953 66976 650717 10.042817 10.018281 9.72 
79 61935.002 62060 64279 585089 9.446823 9.4278435 9.1 
80 58725.438 58831 61261 522319 8.8942547 8.8783371 8.53 
81 55392.344 55451 58082 462648 8.3522012 8.3434301 7.97 
82 51907.384 52011 54689 406262 7.8266707 7.8110962 7.43 
83 48238.745 48332 51078 353379 7.3256259 7.31148 6.92 
84 44403.417 44519 47265 304207 6.8509818 6.8332573 6.44 
85 40481.156 40553 43320 258915 6.3959389 6.3845626 5.98 
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Number of survivors [𝒍𝒙]  
Life-expectancy [𝒆(𝒙,𝒕)] 
Age  CBD LC (Original) 𝑻𝒙 (original) CBD LC (Original) 
86 36500.218 36615 39277 217616 5.9620465 5.9432947 5.54 
87 32392.382 32512 35040 180457 5.5709703 5.5504703 5.15 
88 28599.461 28722 31094 147390 5.1535936 5.1315652 4.74 
89 24780.568 24884 27092 118298 4.7738212 4.7539111 4.37 
90 20989.262 21054 23055 93225 4.4415568 4.4278324 4.04 
91 17558.971 17635 19257 72069 4.1043977 4.0867903 3.74 
92 14336.1 14410 15656 54612 3.8094042 3.7898237 3.49 
93 11532.228 11616 12639 40465 3.5088623 3.483514 3.2 
94 8927.7515 9015 9866 29212 3.2720445 3.2404236 2.96 
95 6701.1404 6773 7441 20558 3.067836 3.035451 2.76 
96 4907.889 4995 5484 14096 2.8721106 2.8221923 2.57 
97 3495.6306 3549 3921 9393 2.6870688 2.6466945 2.4 
98 2413.5099 2477 2714 6076 2.5174954 2.4527921 2.24 
99 1620.3484 1678 1817 3810 2.3513462 2.2710203 2.1 
100 1051.8611 1082 1175 2314 2.1999102 2.1389066 1.97 
Table 4.15 Mortality forecasts for forward look windows h=1, h=5 and h=10. 
 
2012 2016 2021 
Age LC CBD LC CBD LC CBD 
60 0.005932 0.005124 0.005374 0.004565 0.00475 0.003951 
61 0.006581 0.005771 0.005979 0.005155 0.005304 0.004476 
62 0.007069 0.006499 0.00638 0.005821 0.005612 0.005071 
63 0.007902 0.007319 0.007145 0.006572 0.006299 0.005744 
64 0.008671 0.008241 0.007842 0.00742 0.006917 0.006506 
65 0.009693 0.009278 0.00877 0.008376 0.007738 0.007369 
66 0.011236 0.010445 0.010277 0.009453 0.009192 0.008344 
67 0.012199 0.011756 0.011092 0.010669 0.009849 0.009448 
68 0.013369 0.01323 0.012174 0.012038 0.010829 0.010697 
69 0.01483 0.014886 0.013504 0.013581 0.012012 0.012108 
70 0.016859 0.016745 0.015432 0.015319 0.013818 0.013703 
71 0.018842 0.018832 0.017329 0.017275 0.015607 0.015505 
72 0.02066 0.021174 0.018909 0.019475 0.016928 0.017539 
73 0.023076 0.0238 0.021159 0.02195 0.018985 0.019835 
74 0.025883 0.026742 0.023782 0.024732 0.021394 0.022425 
75 0.028864 0.030037 0.026582 0.027856 0.023982 0.025344 
76 0.03254 0.033725 0.030038 0.031361 0.027179 0.028632 
77 0.037729 0.037847 0.035132 0.035292 0.032136 0.032332 
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2012 2016 2021 
Age LC CBD LC CBD LC CBD 
78 0.041054 0.042451 0.038078 0.039696 0.034659 0.036493 
79 0.047279 0.047587 0.044093 0.044623 0.040412 0.041166 
80 0.054001 0.05331 0.050713 0.050131 0.046883 0.046409 
81 0.062213 0.059678 0.058913 0.056278 0.055034 0.052283 
82 0.068913 0.066754 0.065091 0.063128 0.060611 0.058855 
83 0.078026 0.074601 0.073923 0.07075 0.069097 0.066195 
84 0.08723 0.083289 0.082712 0.079215 0.077393 0.074378 
85 0.099923 0.092887 0.095341 0.088595 0.089907 0.083483 
86 0.110689 0.103466 0.105607 0.098967 0.099581 0.093589 
87 0.124287 0.115097 0.118962 0.110406 0.112625 0.104779 
88 0.139569 0.12785 0.134253 0.122987 0.127891 0.117133 
89 0.15803 0.141789 0.152464 0.136781 0.145782 0.130732 
90 0.180758 0.156974 0.175432 0.151854 0.168994 0.145649 
91 0.201095 0.173456 0.196138 0.168265 0.190114 0.161951 
92 0.223848 0.191277 0.218697 0.18606 0.212425 0.179694 
93 0.246884 0.210462 0.241292 0.205272 0.234481 0.198919 
94 0.273167 0.231022 0.267852 0.225918 0.261353 0.219651 
95 0.306824 0.252947 0.302562 0.247992 0.297317 0.241891 
96 0.324435 0.276205 0.318085 0.271467 0.310322 0.265616 
97 0.377464 0.300741 0.374635 0.296288 0.371127 0.290775 
98 0.38211 0.326474 0.375377 0.322374 0.367129 0.317288 
99 0.386938 0.353295 0.380153 0.349616 0.371838 0.345043 
100 0.467674 0.381074 0.469243 0.377877 0.471211 0.373895 
Table 4.16 Mortality forecasts of Australian male for forward look windows h=15, h=20 
and h=50. 
 2026 2031 2061 
Age LC CBD LC CBD LC CBD 
60 0.003251 0.003419 0.002731 0.002958 0.003157 0.001241 
61 0.00367 0.003886 0.003099 0.003373 0.003567 0.001442 
62 0.003785 0.004417 0.003158 0.003847 0.003671 0.001677 
63 0.004278 0.00502 0.003582 0.004386 0.004152 0.00195 
64 0.004704 0.005704 0.003941 0.005001 0.004565 0.002267 
65 0.00527 0.006482 0.004417 0.005701 0.005115 0.002636 
66 0.006526 0.007365 0.005576 0.006499 0.006355 0.003064 
67 0.006837 0.008366 0.005781 0.007407 0.006646 0.003561 
68 0.007558 0.009503 0.006407 0.008442 0.00735 0.004139 
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 2026 2031 2061 
Age LC CBD LC CBD LC CBD 
69 0.008383 0.010793 0.007106 0.00962 0.008152 0.004811 
70 0.009841 0.012256 0.00842 0.01096 0.009585 0.005591 
71 0.011316 0.013914 0.009763 0.012484 0.011037 0.006496 
72 0.012049 0.015792 0.010307 0.014217 0.011735 0.007547 
73 0.013608 0.01792 0.011678 0.016187 0.01326 0.008766 
74 0.015458 0.020329 0.013314 0.018425 0.015073 0.01018 
75 0.017482 0.023054 0.01512 0.020966 0.017058 0.011819 
76 0.019991 0.026134 0.01736 0.023848 0.01952 0.013719 
77 0.02444 0.029613 0.021552 0.027116 0.023926 0.01592 
78 0.025962 0.033539 0.022735 0.030817 0.025386 0.018467 
79 0.030917 0.037966 0.027339 0.035006 0.030281 0.021412 
80 0.036836 0.042951 0.032974 0.03974 0.036153 0.024815 
81 0.044645 0.048558 0.040555 0.045085 0.043926 0.028744 
82 0.048689 0.054854 0.044029 0.05111 0.047868 0.033273 
83 0.056157 0.061914 0.051055 0.057892 0.05526 0.038487 
84 0.0631 0.069815 0.057452 0.065511 0.062108 0.044481 
85 0.07508 0.07864 0.069115 0.074055 0.074036 0.051359 
86 0.083142 0.088474 0.076529 0.083613 0.081985 0.059234 
87 0.095197 0.099406 0.088122 0.094279 0.093962 0.068229 
88 0.110178 0.111523 0.102885 0.106148 0.108909 0.078477 
89 0.127037 0.124912 0.119254 0.119315 0.125686 0.090115 
90 0.150663 0.139656 0.142922 0.13387 0.149325 0.103286 
91 0.172746 0.15583 0.165309 0.149898 0.171466 0.118131 
92 0.194265 0.173499 0.186452 0.167475 0.192921 0.13479 
93 0.21474 0.192715 0.206238 0.18666 0.213278 0.153389 
94 0.242364 0.21351 0.234111 0.207495 0.240949 0.174038 
95 0.28177 0.235892 0.274905 0.229997 0.280598 0.196822 
96 0.287645 0.259846 0.277791 0.254158 0.285955 0.221786 
97 0.360559 0.285323 0.355806 0.279934 0.359751 0.248936 
98 0.342912 0.312245 0.33233 0.307247 0.3411 0.278221 
99 0.347422 0.340497 0.33675 0.335981 0.345594 0.309531 
100 0.477306 0.369931 0.480133 0.365984 0.477783 0.342692 
 
Tables 4.15–4.16 contain forecasted mortality rates for Australian males over 
different values of look forward windows (h=1, h=5, h=10, h=15, h=20 and h=50).  
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Figure 4.12 Mortality forecast - Lee-Carter model. 
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Figure 4.14 Comparative mortality forecasts by the Lee-Carter and CBD models. 
The above graphs (Figures 4.12 to 4.14) are graphical representation of the 
mortality rates predicted by the Lee-Carter and CBD models, illustrating a predicted 
decline in mortality rates over a 50 - year period. The 50–year data from 1961–2011 
for the Australian male population aged 60–100 was fitted into the models to predict 
male mortality for this cohort with a forecasting period of 1 year (2012), 5 years 
(2016), 10 years (2021) 15 years, (2026), 20 years (2031) and fifty years (2061). Based 
on current population figures, the residual life-expectancy for 65-year-old Australian 
men in 2011 was 19.14 years. Using mortality rates predicted by the Lee-Carter and 
the CBD models, the residual life-expectancy for an Australia man aged 65 in 2011, 
was 19.37 years.  
As seen in the previous chapter analysing female mortality and life-
expectancy, the Lee-Carter model had a similar estimate as the CBD model. The t-test 
(P> 0.05) indicated that the statistical goodness-of-fit did not significantly impact on 
the forecasting of life-expectancy, for this dataset, for ages 60–100 years. 
4.5 Discussion 
As mentioned in section 3.8, the development of stochastic mortality models has led 
to many changes in the analysis of population evolution, supporting new hypotheses, 
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projections. The present study evaluates the goodness of fit of six stochastic mortality 
models using Australian male mortality data for a period of 50 years, between 1961–
2011. Starting with the Lee-Carter model, and continuing with five of its extensions, 
the current research has addressed the issue of male mortality and life-expectancy 
forecasting in Australia. Due to the limited number of studies on the topic of male 
mortality forecasting in Australia, the current study can be considered a great 
contribution to the existing literature. The results obtained, in combination with others, 
contribute to the study of the Australian demographic component and its implications 
for the development of the country. 
The objective of understanding the dynamics of mortality, based on the 
demographic perspective used to be based only on linear studies using age and known 
information, which generated over-estimates and inaccurate information. Such results 
did not allow for a very thorough analysis in terms of insurance and pensions to be 
performed. Studies of this type began with deterministic models such as that of 
Gompertz in 1825 (Gompertz 1825) which presents a satisfactory estimate of 
mortality. However, the main disadvantage of the model is that for ages greater than 
80 years, the mortality indicator is overestimated (Koissi and Shapiro 2008). 
In 1980, Heligman and Pollard (1980) in their article called “The age pattern 
of mortality” continued developing the subject of dynamic mortality models. Starting 
from interpolations, Helligman and Pollard took initial steps toward the objective of 
mortality projection in order to structure the actuarial studies that sustain the insurance 
and pension business. More recently, the attention of researchers has focused mainly 
on the stochastic model presented by Lee and Carter. Since first presented by the two 
authors in 1992 in their article called “Modeling and forecasting US mortality”, this 
model has been used for demographic and actuarial applications around the world. 
The popularity of the Lee-Carter model and its extensions, as well as their 
simplicity of use and understanding, represent the main reasons for choosing these 
methodologies. Thus, the analysis performed in this chapter involved applying the Lee-
Carter model and five of its extensions (RH, APC, CBD, M7 and Plat) on Australian 
male mortality data with the purpose of choosing the best-fitted model to predict male 
mortality in Australia. Based on a comparison between the six models, the Lee-Carter 
model has proved to be the most appropriate to forecast male mortality rate and life-
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expectancy in Australia for a window of 50 years. Results showed that the Lee-Carter 
model gave a comparatively good fit to the Australian data for both females and males. 
The approach of the Lee-Carter model is based on the projection of the 
historical tendency presented by the variable, Kt. Likewise, its probabilistic 
composition allows, through time series, to generate analysis on the future behaviour 
life such as forecasts, and confidence intervals. Despite its limitations, the approach 
defined by Lee and Carter in 1992 is widely used in the demographic environment and 
manages to be present in a large percentage of the studies on the subject. The most 
important differentiation presented by Lee and Carter in their article was the 
incorporation of the information in two dimensions, which is mortality through periods 
of time. Specifically, the model assumes that the mortality dynamics responds to a 
parameter, the mortality rate, generated by the regression. Starting from this index, the 
behaviour of mortality using a classic model of time series such as Box-Jenkins can be 
forecasted. Moreover, the model suggests several conclusions about life-expectancy 
and mortality tables. 
The Lee-Carter model, designed to predict mortality and to analyse its 
dynamics, has the purpose of analysing the interaction between variables such as 
mortality rate, life-expectancy, and mortality index. However, beyond this intention, 
the model is limited by the existing patterns in this area, which means it does not 
include information regarding accidents, advances in medicine, wars or other events 
that may mark an inflexion point (Lee 2000). 
The Lee-Carter forecasts of mortality rates are comparable to the official 
mortality rates, while the forecasts of life-expectancy are a little higher than official 
numbers but the difference is not significant. On the other hand, experience has shown 
that the Lee-Carter method has proved to under predict life-expectancy (Lee and Miller 
2001: pp 537–549). Therefore, the observed values of life-expectancy could even be 
higher than the Lee-Carter forecasts. 
Similar to the Australian female dataset, for the male mortality data the 
comparison techniques used revealed there are some notable differences amongst the 
six different models. However, none of the models analysed performs well in all tests 
and no model clearly dominates the others. This conclusion is consistent with the 
conclusion formulated by Dowd et al. (2010a) after assessing the goodness of fit of 
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several mortality models applied to the English and Wales male data. For the 
Australian male dataset considered we find that the Lee-Carter model gives the lowest 
RMSE for all look forward windows and is better suited for non–stratified data. 
However, this model does not clearly stand out from the rest of the models analysed. 
The Plat model gave a comparatively good fit to the Australian male mortality data, 
while the Cairns-Blake-Dowd model gave the poorest fit to this data. 
However, when the data was fitted into the Lee-Carter and CBD models to 
calculate male mortality rates, the two models showed comparable results. Similarly, life-
expectancy was comparable between the Lee-Carter and CBD forecasts. For example, 
the mortality rate predicted by the Lee-Carter model for an 80–year–old Australian man 
in 2011 is 0.054, while the CBD model predicted a mortality rate of 0.057 for the same 
individual. Also, using mortality rates predicted by the Lee-Carter model, the residual 
life-expectancy for an Australia woman aged 80 in 2011, is 9.00 while the CBD model 
gives a residual life-expectancy of 9.02 years, for the same individual. 
Tabeau, van den Berg Jeths, and Heathcote (2001) described in their paper the 
models of graduation and prediction recently developed and concluded that there is a 
need to integrate techniques from different disciplines with the aim of obtaining 
satisfactory predictions. The Lee-Carter model and its extensions have been used to 
predict mortality rates in many countries, starting with the United States (Lee and Carter 
1992), Canada (Lee and Nault 1993), Chile (Lee and Rofman 1994),  Australia (Booth, 
Maindonald and Smith 2001; Booth and Tickle 2003; Booth 2004; and Erbas, Ullah, 
Hyndman, Scollo and Abramson 2012), England and Welsh (Renshaw and Haberman 
2003; Griffiths and Brock 2003) and Spain (Debón et al. 2008;  Debón, Martínez-Ruiz 
and Montes 2010; and Debón, Montes and Martínez-Ruiz 2011). 
Mortality rates were forecasted for men in Australia for period of 1, 5, 10 and 
15, 20 and 50 years, using the CBD and Lee-Carter models. A cohort of 60–100 years 
was selected, based on statistical selection criteria. Mortality rates obtained by both 
models showed a continuing trend in declining mortality. The Lee-Carter and CBD 
models were conservative in their prediction, estimating a steady fall in mortality rates 
from 0.006 in 2011 to a predicted 0.004 in 2021 (Lee-Carter) while with the CBD 
model, mortality rates declined from 0.005 in 2011 to 0.003 in 2021. Further 
forecasting indicated the Lee-Carter model is more conservative in its prediction than 
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the CBD model, predicting a decline to 0.003. On the other hand, the CBD model 
predicted a further decline in male mortality rates of 0.001 in 2061.  
The forecasting results obtained in the current study indicate that in the long-
term there is a decreasing trend in mortality rates and an increasing trend in life-
expectancy for the Australian male population. The increasing trend in life-expectancy 
projections and the decreasing trend in mortality rates are consistent with most of the 
results in the literature when applying the Lee-Carter model to different datasets from 
different countries.  
These methods, however, have several weaknesses. First of all, it is likely to 
obtain biased results by directly projecting life-expectancy, since it is simply a 
synthetic and non-linear measure of death rates by age. Even if these mortality rates 
continued to fall at constant exponential rates according to age, life-expectancy would 
increase at a decreasing rate due to the reduction in entropy. 
Booth et al. (2006) proved that the Lee-Carter model and its extensions tend to 
underestimate errors for the younger ages (0–40) and overestimate errors for higher age-
groups (60–100). However, the life-expectancy calculated by the Lee-Carter model, 
which had a low RMSE did not significantly differ from the life-expectancy calculated 
by the CBD model, in which the error was notably overestimated. Hence, the current 
study agrees with Booth’s hypothesis that over-estimation or underestimation error does 
not translate into an erroneous estimation of life-expectancy. 
The results obtained after applying the Lee-Carter and CBD models suggest 
that male mortality in Australia has been decreasing in the last decades and, looking at 
the mortality rates forecasts for the next 50 years, it can be concluded that this 
population factor will continue to decrease. One of the implications of this research 
for practice is that the implementation of a model such as the Lee-Carter model for the 
demographic information of a country can suggest population dynamics that allow 
revising the formulations that base the models for pension and insurance funds. The 
main implication for research is the suggestion that none of the models analysed 
performs well in all tests and no model clearly dominates the others. Also, this research 
disclosed further research paths concerning mortality rate analysis in Australia, which 
may help in fostering research on this topic. 
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The contributions and implications of this research are logical to consider that 
both female and male mortality and life-expectancy in Australia will continue to 
improve gradually over time, due to a variety of factors, rather than experiencing a 
substantial abrupt improvement. Among these factors might be great medical 
advances, greater access to health, reductions in tobacco consumption, etc. 
4.6 Conclusions  
Male mortality and life-expectancy rates in Australia have significantly improved in 
the last 60 years with particularly high rates of mortality improvement for the cohort 
of Australian males born in 1925–35. However, historical rates of mortality 
improvement have shown significant variations by age, time and cohort (Berry, Tsui 
and Jones 2010). 
Although there is a growing range of models that can be used for forecasting 
mortality and life-expectancy rates, none of these models has proved to be ideal. 
Research in this area shows that a combination of extrapolation and explanation is 
required to ensure that forecasts are reasonable and take into account all the 
information that is available and relevant (Cairns et al. 2011). 
Dowd et al. (2010a and b) use goodness-of-fit tests and out-of-sample back-
testing to show that under some criteria, some models are better than others but none 
of the models is superior under all the criteria considered. 
From The current study, based on the results of the RMSE for various look 
forward windows, it may be inferred that the Lee-Carter model and Plat model are 
more suited fit to non-stratified model for ages 0 to 100 (See Tables 4.1–4.4). Results 
across all look back windows are comparable, hence for computational convenience data 20 
can be used for modelling within above settings, for ages 60 to 100 or 80 to 100, providing 
an improvement in model fit compared to model fitted for all ages (See Tables 4.8 and 
4.11). 
The present study brings empirical evidence and arguments in favour of long-
term declining trends in male mortality by selecting the best mortality model using 
statistical criteria. However, the degree of uncertainty with which the predictions are made 
is that it incorporates, and flexibility and robustness of forecasting are features that should 
also be considered in choosing the best stochastic model for predicting human mortality. 
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The results obtained in this chapter allowed the projection of male life-
expectancy and mortality tables in Australia for the period 2012–2061. According to 
the forecasts, a life-expectancy of 28.72 years is estimated by 2061 for age 60, that is 
to say, an increase of 5.5 years with respect to the life-expectancy at birth observed in 
2011. From a social, economic and individual point of view, living longer is, in itself, 
a fact of great importance. But the utility of the presented results must also be measured 
in terms of their possible applications. 
In this sense, the projection of life-expectancy and mortality tables has direct 
implications on the calculation of premiums and annuities in the insurance industry. If 
dynamic or cohort tables are considered for the death insurance quote, the premiums 
would decrease their level by increasing the ability to be placed in the market, as a 
result of considering possible future reductions in the risk of death in the quotation. 
It is important to consider the case of life insurance, in which the projected 
life-expectancy gains during the rest of the passive stage will relativize the periodic 
purchasing power of the capital with which the rent is purchased (the retirement). 
Furthermore, at the same time, the premium would be higher because of the projected 
improvements in survival, which would result in a commercial and technical problem 
(in terms of maintaining in real terms the income from the current static tables). 
In social security, the use of these values affects the projected estimates of 
pensions for death and retirement pensions. In the first case, it concerns not only the 
expected amount of discharges per year but also the expected amount to be paid, since 
the surviving beneficiary will have an expected future mortality reflected in tables such 
as those presented in the present study. 
With respect to the retirement and pension scheme (Antolin 2007), the 
expected increase in lifespan can be used to plan progressive changes with the 
objective of maintaining the financing of years gained in longevity. 
Finally, from a methodological point of view, one of the main merits of the 
Lee-Carter model is that incorporates the analysis of mortality level and structure, 
allowing an easy stochastic projection of mortality. 
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Chapter 5 Summary, Conclusions and Recommendations 
5.1 Summary of the work 
The main purpose of this research is to analyse female and male mortality in Australia 
and to forecast mortality rates and life-expectancy. This is done by choosing the most 
appropriate model after comparing six stochastic models used in the empirical 
literature for mortality and life-expectancy forecasting (Lee-Carter, Renshaw-
Haberman, Age-Period-Cohort, CBD, M7 and Plat).  
The analysis presented in Chapter 3 and Chapter 4 of this thesis illustrates the 
results obtained after applying the Lee-Carter model and its extensions, which are 
Renshaw-Haberman-RH, Cairns-Blake-Dowd-CBD, Age-Period-Cohort-APC, M7 
and Plat models, to forecast the mortality rate and life-expectancy of the Australian 
population. Mortality data from the Human Mortality Database was applied to each of 
the models, separately for men and women. A comparison was made between the six 
mortality models using different criteria (root mean square error, Bayesian Information 
Criterion and Akaike Information Criterion) in order to choose the best model to be 
used for mortality and life-expectancy forecasting.  
The comparison of models with measures of goodness of fit showed that the 
original Lee-Carter provides better prediction results of mortality rates and life-
expectancy than the other models. The comparison shows that, despite the greater 
complexity of the extended models, this model better describes Australian data. 
Furthermore, the general index of mortality and its future projections were calculated 
between the years 2012 and 2061, using the best-fitted model for the Australian data 
(the Lee-Carter model). The results were then compared with the forecasted values 
given by the CBD model. Furthermore, one mortality indicator was calculated: life-
expectancy. The improvement in mortality rates and life-expectancy reflects the 
increase in the standard of living in the Australian population during the last decades. 
The analysis started by comparing the root mean square values, for five 
different looks back windows (h=1, h=5, h=10, h=15 and h=20) for each of the three 
scenarios considered (S0, S1 and S2). For scenario S0 (non-stratified data, 0–100 
years), the results were similar for both male’s and female’s data, providing evidence 
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that the differences in the goodness of fit, as measured by the RMSE values between 
the five look back windows were not significant (p-value < 0.05 for all the six models). 
The Lee-Carter model gave the lowest root mean square values for almost all look-
back windows considered (h=1, h=5, h=10, h=15 and h=20), followed by the Plat 
model, for both male and female mortality data. 
For scenario S1 (stratified data, age cohort 0–40 years), the models with the 
best fit for short-term and long-term forecasting (h =1 and h=20) were the APC and 
Plat models for both females and males data. For scenario S1 (stratified data, age 
cohort 40–60 years), the models with the best fit for short-term and long-term 
forecasting (h =1 and h=20) for female data were the CBD, APC and LC models, while 
for male data, the APC and Plat models proved to be the best-fitted. For the same 
scenario S1 but age cohort 60–100 years, the best-fitted models were the APC, Plat 
and Lee-Carter, for both male and female data. 
For scenario S2 (stratified data, age cohort 0–60 years), the models with the 
best fit for short-term and long-term forecasting (h =1 and h=20) were the RH, Lee-
Carter and Plat models for female data. The Plat and the APC models proved to be the 
best models for the same scenario. Results showed that for age cohort 60–80 years, for 
female data, the best-fitted models for short-term and long-term forecasting (h =1 and 
h=20) were the Lee-Carter, Plat and RH models. On the other hand, the analysis 
conducted for male data revealed that the APC model was the best fitted from all six 
models. Finally, for scenario S2, stratified data, age cohort 80–100 years, the models 
with the best fit for short-term and long-term forecasting (h =1 and h=20) were the 
APC, M7 and Plat models. 
Furthermore, a comparative analysis of the root mean square values between 
the six different mortality models for the three scenarios with the different look back 
windows was presented for both female and male mortality data. The results for female 
data supported the hypothesis that the variance in RMSE for the different data sizes 
(data=20, 30, 40 and 50) is not statistically significant, except for scenario S0 where 
the CBD and the M7 models were significantly different in the goodness of fit 
compared to the other four models. The results for male data supported the hypothesis 
that the variance in RMSE for the different data sizes (data=20, 30, 40 and 50) is 
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statistically significant, showing that the means of observations grouped by different 
data sizes are different.  
Comparing the root mean square values between the six models estimated for 
both male and female data and all look back windows considered (20, 30, 40 and 50), 
the Lee-Carter model proved to be the best-fitted model for scenario S0. Furthermore, 
age cohort 60–100 years (S1) was selected to determine the differences between 
RMSE for stratified data using varying periods of forecasting (Data=20 – Data=50), 
as this comprised the pensionable population. In this case, the analysis performed for 
female mortality showed the Lee-Carter model was best fitted, while for male 
mortality, the APC model was superior to the other five models considered.  
Finally, for scenario S2, female data, the APC was best fitted for ages 0–60 
and 60–80, while the Lee-Carter model was best fitted for the older ages of 80–100 
years. On the other hand, for the same scenario, age cohort 0–60 years, the Plat model 
was the best-fitted model, while for ages 60–80 and 80–100 the Lee-Carter and CBD 
models gave the best fit. 
Next, the Bayesian and Akaike Information Criteria (BIC and AIC) were 
compared with the purpose of choosing the best model between the six mortality 
models estimated in the previous chapters of this thesis. Thus, a comparison was made 
first of all between the BIC scores obtained for the six different models (Lee-Carter, 
RH, APC, CBD, M7 and Plat) for a data mined between the 20–year period 1990–
2010, for female and male data. This comparison showed that the BIC values 
decreased with increasing ages in the case of stratified data and the models with the 
lowest BIC values were the Lee-Carter model and the APC model for both female and 
male data. Furthermore, a comparison between the AIC scores obtained for the six 
different models was made. In this case, results showed the models with the lowest 
AIC values were RH model and the Plat for female data. The values for the Lee-Carter 
model and the APC model were not statistically different from the RH or Plat models 
as indicated by the student’s t-test (p-value > 0.05). The same comparison analysis 
between the AIC values, obtained for the six mortality models estimated for Australian 
male mortality data showed that the Plat, APC and RH models were the best-fitted 
models. 
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Other criteria to be satisfied when choosing the best mortality model were the 
randomness of residuals. For both datasets (female and male mortality), the residuals 
for the Lee-Carter models were randomly distributed. 
In summary, based on the four criteria for model selection analysed in the 
sections of previous chapters, the best model for estimating mortality and life-
expectancy for female and male datasets is the Lee-Carter model. As a comparison, 
the CBD models had the highest values of root mean square error as well as BIC and 
AIC, suggesting a poor selection for both datasets. Because there was no significant 
difference in the goodness-of-fit for the Australian female and male mortality data, 
between the different data sizes (data=20, data=30, data=40 or data=50), a dataset 
of 50 years was chosen to calculate mortality and life-expectancy. Thus, the Lee Carter 
and the CBD models were used to calculate mortality rates, the number of deaths, the 
number of survivors, and life-expectancy in 2011 for age cohort 60–100 years. 
Furthermore, mortality rates and life-expectancy were forecasted for a period of 50 
years, between 2012 and 2061 using the Lee Carter and the CBD models. 
Comparing the mortality rates over different values of h (h=1, h=5, h=10, 
h=15, h=20 and h=50), results showed they were not statistically different between 
the Lee-Carter model and the CBD model. Similarly, the difference between the CBD 
and the Lee-Carter life-expectancy forecasting results were not significantly different, 
indicating that the statistical goodness-of-fit did not have any significant impact on the 
forecasting of life-expectancy, for age cohort 60 – 100 years. 
Based on current population figures, the residual life-expectancy for a 65–
year–old Australian woman in 2011 was 22.06 years. Using mortality rates predicted 
by the Lee-Carter model, the residual life-expectancy for an Australian woman aged 
65 in 2011 was 22.081 while the residual life-expectancy for 65–year–old Australian 
men in 2011 was 19.14 years. Using mortality rates predicted by the Lee-Carter model, 
the residual life-expectancy for an Australia men aged 65 in 2011, was 19.37 years.  
One important aspect regarding data availability is that it has been easy to 
access the Human Mortality Databases with information on the number of deaths, 
number of survivors, life-expectancy, death rates, population size, etc. Thus, it can be 
said that at country level there is a good source of information about what is happening 
in Australia’s demographics. Starting with 1921, the Human Mortality Database 
provides detailed information about mortality and population data. 
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5.2 Contributions 
The purpose of this thesis is to examine in detail, the mortality patterns in Australia, 
over the period 1961– 2061, to analyse and predict mortality rates and life-expectancy, 
as well as to detect and model the eventual presence of cohort effects in mortality 
patterns. These contributions are important in selecting accurate models on which to 
base future forecasts. 
The comparison of the six mortality models (starting with the original Lee-
Carter model and ending with one of its most recent extension), with the purpose of 
selecting the best model for Australian mortality and life-expectancy forecast represent 
contributions highlighting the originality of the thesis.  
Among the most important results and conclusions learned from this analysis, 
we mention the following: 
 The results of this analysis contribute to the existing empirical literature by 
considering not only the Lee-Carter model but also a selection of extensions from 
the Lee Carter model to estimate and forecast Australian mortality rates and life-
expectancy. 
 The main contribution of this research is the comparison of six different stochastic 
mortality forecasting methods estimated for the Australian mortality data, based 
on three different criteria (RMSE, BIC and AIC values). This comparison is a 
useful method contributing to the identification of the most appropriate model to 
be used for mortality and life-expectancy forecasting. 
 The separation of age, period and cohort patterns can contribute in important ways 
to a better understanding of the mortality rate decline in Australia over the last 
decades. 
5.3 Limitations and directions for future research   
As a result of the estimation of the Lee-Carter model and its extensions for the 
population of Australia, a prognosis of the future mortality rates and life-expectancy 
for the next 50 years has been made. While the current study concurs with arguments 
in favour of long-term declining trends in mortality, the degree of uncertainty with 
which these predictions are made is not well defined. Although the selection of 
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mortality models is based on statistical criteria, additional considerations such as 
flexibility and robustness of forecasting are features that need to be considered in 
choosing the best stochastic model for predicting human mortality.  
A challenging problem for the study of human longevity is the available 
demographic data for the elderly. Because the numbers of observations for the elderly 
are seldom sufficient, false decisions may be caused by their graduated mortality rates 
that are likely to be very different from the true values.  
The analysis and the results presented generated a set of questions which can 
reinforce even more the interest in the field of stochastic mortality forecasting and can 
guide future research efforts. Thus, based on the set of limitations discovered and 
described, a set of directions for future research can be learnt and taken into 
consideration for future analysis. 
One of the main contributions of this research refers to direct implications for 
the projections of life-expectancy and mortality tables on the calculation of premiums 
and annuities in the insurance industry. Under the assumption that insurance and 
pension companies are regionally concentrated, it would be interesting for future 
research purposes to conduct a study that differentiates the mortality rates by regions. 
This may suggest a differential risk per region and therefore higher or lower pension 
costs for different participants in the sector. However, data availability may limit the 
analysis conducted and its results.  
After modelling the mortality curve using the best statistical method chosen 
from six mortality models based on the original Lee-Carter approach, it would be 
interesting to implement a more complex model based on a stochastic differential 
equation (SDE). For example, Milevsky and Promislow (2001) have studied mortality 
patterns using stochastic differential equations associated with an additive noise based 
on Brownian motion. Also, Giacometti, Ortobelli and Bertocchi (2011) make a 
generalisation of SDE models, considering the case with an additive noise but with a 
diffusion coefficient dependent on time and not only as a constant function. The 
authors conclude that the use of stochastic mortality equations to model the mortality 
rates and life-expectancy reflects more accurately the behaviour of mortality and opens 
a field in the study of this subject. 
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Some authors in their models tried to adjust the mortality rate by assuming 
perfect correlations between generations. However, common intuition suggests that 
between close generations these correlations are high but not perfect. To explain this 
relationship, Giacometti, Bertocchi, Rachev and Fabozzi (2012) consider short-
dependency models such as ARMA (p, q), and in particular, suggest the use of an AR 
(1). The approach that could be explored in a future study is to describe mortality with 
a model that takes into account long-range dependence. For this it would be 
appropriate to use a generalisation of the Milevsky-Promislow model, integrating this 
dependence. The research would try to fit a stochastic differential equation with 
additive noise based on a fractional Brownian motion (fBm), instead of the standard 
Brownian motion.  
According to the Milevsky-Promislow model, the mortality 𝑚𝑥(𝑡) is given 
by the following equation: 
 
𝑚(𝑡) = 𝑚0𝑒𝑥𝑝 (𝛼0𝑡 + 𝛼1𝑌𝑡) (5.1) 
where: ℎ0, 𝛼0, 𝛼1 > 0. 
The stochastic process 𝑌𝑡 (fractional Ornstein-Uhlenbeck process) satisfies 
the stochastic differential equation: 
 
𝑑𝑌𝑡 = −𝜆𝑌𝑡𝑑𝑡 + 𝛾𝑑𝐵𝑡
𝐻 (5.2) 
 
𝑌0 = 0 (5.3) 
where 𝐵𝑡
𝐻 is a fractional Brownian motion with a Hurst parameter 1/2 ≤ H < 1 and 
parameters λ, γ > 0. 
Using real historical data from the Australian population, the main objective 
would be to estimate the parameters H,𝛾,𝜆,𝛼0, 𝛼1. 
Another direction for future research would be to use other models that 
overcome the limits of the Lee-Carter model and its extensions by trying to understand 
how risk factors (like smoking, hypertension, etc.) will affect the different causes of 
death. In order to do this, multivariate models such as generalised linear models 
(GLM) could be used, which also attempt to measure changes in mortality by 





Appendix A R Code Excerpt 
This appendix shows an R Code excerpt illustrating R commands and input-output that 
were used. 

















Appendix B Results of the goodness-of-fit criteria of data 
20 and h=1, using different mortality models, 
for Australian data 
This appendix shows tables of modelling results using RH, APC, CBD, M7 and Plat 
models for 1–year look forward window and 20–years look back window, for both 
female and male Australian data. 
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Table B.1 The results of the goodness of fit criteria of data 20 and h=1 using RH model, Australian females. 
 Age Full Age Stratified 
  Scenario 1 Scenario 2 
LC S0 S1A S1B S1C S2A S2B S2C 




























































































































 Age Full Age Stratified 
  Scenario 1 Scenario 2 
LC S0 S1A S1B S1C S2A S2B S2C 




















































































Table B.2 The results of the goodness of fit criteria of data 20 and h=1 using APC model, Australian females. 
 Age Full Age Stratified 
  Scenario 1 Scenario 2 
LC S0 S1A S1B S1C S2A S2B S2C 













































































































































 Age Full Age Stratified 
  Scenario 1 Scenario 2 



































































Table B.3 The results of the goodness of fit criteria of data 20 and h=1 using CBD model, Australian females. 
 Age Full Age Stratified 
  Scenario 1 Scenario 2 
LC S0 S1A S1B S1C S2A S2B S2C 










































 Age Full Age Stratified 
  Scenario 1 Scenario 2 
LC S0 S1A S1B S1C S2A S2B S2C 




























































































































 Age Full Age Stratified 
  Scenario 1 Scenario 2 
LC S0 S1A S1B S1C S2A S2B S2C 










































Table B.4 The results of the goodness of fit criteria of data 20 and h=1 using M7 model, Australian females. 
 Age Full Age Stratified 
  Scenario 1 Scenario 2 
LC S0 S1A S1B S1C S2A S2B S2C 



























































 Age Full Age Stratified 
  Scenario 1 Scenario 2 






















































































































































Table B.5 The results of the goodness of fit criteria of data 20 and h=1 using Plat model, Australian females. 
 Age Full Age Stratified 
  Scenario 1 Scenario 2 
LC S0 S1A S1B S1C S2A S2B S2C 













































































































































 Age Full Age Stratified 
  Scenario 1 Scenario 2 



































































Table B.6 The results of the goodness of fit criteria of data 20 and h=1 using RH model, Australian males. 
 Age Full Age Stratified 
  Scenario 1 Scenario 2 
LC S0 S1A S1B S1C S2A S2B S2C 










































 Age Full Age Stratified 
  Scenario 1 Scenario 2 
LC S0 S1A S1B S1C S2A S2B S2C 




























































































































 Age Full Age Stratified 
  Scenario 1 Scenario 2 
LC S0 S1A S1B S1C S2A S2B S2C 










































Table B.7 The results of the goodness of fit criteria of data 20 and h=1 using APC model, Australian males. 
 Age Full Age Stratified 
  Scenario 1 Scenario 2 
LC S0 S1A S1B S1C S2A S2B S2C 



























































 Age Full Age Stratified 
  Scenario 1 Scenario 2 






















































































































































Table B.8 The results of the goodness of fit criteria of data 20 and h=1 using CBD model, Australian males. 
 Age Full Age Stratified 
  Scenario 1 Scenario 2 
LC S0 S1A S1B S1C S2A S2B S2C 













































































































































 Age Full Age Stratified 
  Scenario 1 Scenario 2 



































































Table B.9 The results of the goodness of fit criteria of data 20 and h=1 using M7 model, Australian males. 
 Age Full Age Stratified 
  Scenario 1 Scenario 2 
LC S0 S1A S1B S1C S2A S2B S2C 










































 Age Full Age Stratified 
  Scenario 1 Scenario 2 
LC S0 S1A S1B S1C S2A S2B S2C 




























































































































 Age Full Age Stratified 
  Scenario 1 Scenario 2 
LC S0 S1A S1B S1C S2A S2B S2C 










































Table B.10 The results of the goodness of fit criteria of data 20 and h=1 using Plat model, Australian males. 
 Age Full Age Stratified 
  Scenario 1 Scenario 2 
LC S0 S1A S1B S1C S2A S2B S2C 



























































 Age Full Age Stratified 
  Scenario 1 Scenario 2 




















































































































































l: look back window 20–years 
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t: year of prediction 
[t–h– l, t–h]: modelling time 
Scenario 0 (S0): [0–100] 
Scenario 1 (S1): S1A=[0–40], S1B=[40–60], S1C=[60–100] 
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